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 The ability to repair damaged mammalian axons to re-establish functional 
connections continues to be a goal for neuroscientists.  Following axonal 
severance, proximal segments of mammalian axons seal themselves rapidly at 
the lesion site.  Distal segments of severed mammalian axons undergo Wallerian 
degeneration within 24-72 hours.  Prior to the onset of degeneration, distal 
axonal segments remain electrically excitable.  
 The work described in this dissertation demonstrates that polyethylene 
glycol (PEG), a hydrophilic polymer, can rapidly repair severed axons by fusing 




      
This plasmalemmal fusion restores morphological integrity of severed axons and 
their ability to conduct action potentials across the injury site.  The ability to fuse 
proximal and distal severed axonal segments using PEG is improved when the 
axonal segments are exposed to antioxidants, such as melatonin and methylene 
blue, and also when microsutures provide additional support in transected sciatic 
nerves.  The restoration of axonal continuity by PEG-fusion restores function, 
improving behavioral recovery in rats with crush-injured sciatic nerves, as well as 
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For over a century, biologists have known that distal segments of severed 
mammalian PNS axons undergo Wallerian degeneration within 12-48 hours 
(Waller, 1850).  If proximal axonal segments survive axotomy, regeneration by 
outgrowth can occur a rate of 1-2 mm/day.  Such PNS axonal regeneration may 
take months to years to reach denervated target tissues in larger mammals such 
as humans (Ingoglia and Murray 2001).  Furthermore, if target tissues are not 
reached, behavioral recovery is typically poor.   
In the last several decades, various procedures have been used to increase 
the number of PNS axons that re-establish connections following severance, but 
not the rate at which PNS axons re-establish those connections.  For example, 
nerve grafts (Lago et al. 2007), connective tissue matrices (Bozkurt et al. 2007), 
and nerve growth guides (Kalbermatten et al. 2009) have all been reported to 
improve the extent of regeneration by severed PNS axons.   
Our lab has developed a technique to improve the speed of PNS repair using 
solutions of polyethylene glycol (PEG) to rapidly (within minutes) and directly re-
establish physiological and morphological continuity.  Initially, it was 
demonstrated that PEG solutions could induce fusion in vitro between the 
severed ends of a myelinated medial giant axon in the CNS of earthworms or 
unmyelinated medial giant axons in the CNS of crayfish (Krause and Bittner, 
1990; Krause et al., 1991).  Because such large-diameter invertebrate axons are 
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uniquely identifiable and have well-characterized behaviors associated with their 
function, we have been able to demonstrate that PEG-fusion can produce long-
lasting in vivo behavioral recovery (in addition to morphological and functional 
continuity) (Lore et al., 1999).   
In contrast to these large-diameter invertebrate axons, mammalian nerves 
have large numbers of small diameter axons that run in parallel and it has not 
been definitively shown whether direct application of PEG to severed mammalian 
PNS nerves in vivo will result in rapid and long-lasting repair.  Recently we have 
shown that PEG fusion re-establishes the continuity of crush-severed rat sciatic 
axons in vitro as measured by the restored conduction of compound action 
potentials (CAPs) and the intra-axonal diffusion of fluorescent dye across the 
lesion site.  These assessments demonstrate axonal continuity of repaired 
mammalian axons.  
This PEG-fusion technique and its rationales are as follows:  Ca2+ influx 
through partially constricted axonal ends and nearby small holes produced by the 
trauma of crush- or cut-severance induces vesicles derived from nearby 
undamaged membranes (Eddleman et al. 1997), lysosomes (Reddy et al. 2003) 
and/or myelin delaminations (Ballinger et al. 1997) to migrate, accumulate and 
pack tightly at the damage site.  These membrane-bound structures interact with 
each other and nearby, undamaged membrane to continuously reduce the influx 
and efflux of ions and other substances until a complete seal is formed in 10-20 




      
repaired and vesicles are no longer observed 24 hours after severance (Lichstein 
et al. 1999).  Vesicle interactions are practically impossible to image in vivo in 
small-diameter unmyelinated or myelinated mammalian axons, but biochemical 
and dye exclusion data show that the same proteins and processes are involved 
with similar time courses as in invertebrates (Bittner and Fishman 2000; Detrait 
et al. 2000a,b; Yoo et al. 2003, 2004; Nguyen et al. 2005). 
Bathing recently-severed axons in Ca2+-free hypotonic saline opens severed 
axonal ends, flushes out most previously formed vesicles, and prevents new 
vesicle formation.  PEG applied in pure H2O to proximal and distal ends of 
severed axons removes waters of hydration from membrane proteins so that 
plasmalemmal lipids flow together at points where axonal open ends are closely 
apposed (Krause and Bittner 1990; Krause et al. 1991; Lore et al. 1999).  That is, 
two open, largely vesicle-free, axonal ends can be more easily fused by PEG 
than two constricted ends filled with vesicles.  The subsequent application of 
Ca2+-containing isotonic saline to the lesion site induces vesicles to seal any 
remaining plasmalemmal holes.  Crush-severed nerves that are PEG-fused may 
be mechanically weak at the lesion site because severance disrupts the 
extracellular matrix (ECM) that normally prevents intact axons from tearing when 
stretched or stressed by joint or muscle movements (schematic of PEG-fusion 
rationale shown in Fig. A1.1).  
Chapter one presents evidence that local application of the antioxidant 




      
success of PEG-fusion in vitro and in vivo.  As oxidative stress following injury 
can lead to Ca2+ - induced apoptosis, we chose to apply melationin in vitro and in 
vivo to severed mammalian PNS axons because melatonin acts as an 
antioxidant (Liu et al., 2004) and combats oxidative stress brought about by free 
radicals produced following injury (Fujimoto et al., 2000).  Furthermore, melatonin 
decreases lipid peroxidation following injury to nervous tissue – thus providing 
protection from secondary injury (Kaptanoglu et al., 2000).  Melatonin also 
inhibits nitric oxide production and may have neuroprotective effects (Rogerio et 
al., 2002).  Results from the experiments outlined in this section suggest that the 
application of melatonin increases the survival of severed distal axonal 
segments, enhancing the success of PEG-fusion in severed mammalian PNS 
axons.   
In chapter 2 we investigate whether PEG-fusion of crush-injured mammalian 
PNS axons in vivo restores not only axonal continuity, but appropriate behavioral 
function.  In the human PNS, crush injuries are the most common type of 
traumatic axonal injury.  Following crush injury of peripheral nerves, the ECM is 
not completely disrupted and the severed ends of axons are closely apposed 
within their endo-, peri-, and epineurial sheaths (Bozkurt et al., 2007, 2008).  
Through a series of experiments we attempt to show that PEG-fusion is a useful 
strategy for rapidly repairing crush-severed axons, providing lasting behavioral 




      
Finally, in chapter three we outline a detailed approach to treat nerve 
severance injuries, combining microsutures, application of antioxidants, and 
PEG-fusion.  Cut injuries completely disrupt the ECM, severing endo-, peri-, and 
epineurial sheaths.  This may account for observed differences in recovery of 
function between crush and cut injuries (de Medinaceli, 1982; Carlton and 
Goldberg, 1986).  Cut-severed axons PEG-fused in mammals in vivo have poor 
mechanical strength at the lesion site and may immediately pull apart after 
animals recover from anesthesia, thereby preventing chronic recovery (Lore et al. 
1999; Bittner and Fishman, 2000).  Using microsutures to bring proximal and 
distal severed axonal segments in close apposition, we attempt to show that local 
application of the antioxidant methylene blue as well as PEG can fuse adjacent 
axonal ends and rapidly restore behavioral function in vivo.   
  In summary, prognosis for those recovering from traumatic nerve injury 
has traditionally been poor.  Frequently, what minimal amount of function does 
return happens very slowly over time, limited by a slow rate of axonal outgrowth 
from the site of injury.  It is hoped that this work will introduce new and novel 
approaches in the treatment of traumatic nerve injury; treatments that encourage 








      
Chapter One: Melatonin enhances PEG-fusion repair of severed rat sciatic 
axons 
INTRODUCTION 
 For almost a century, injury to peripheral nerve axons in mammals and 
other vertebrates has been known to result in Wallerian degeneration of the 
severed distal stumps and slow (1 mm/day) outgrowths from the severed 
proximal stumps that can produce functional recovery (Ingoglia & Murray, 2001). 
It is less widely known that the hydrophilic polymer polyethylene glycol (PEG) 
can repair severed axons by fusing the plasmalemmas of the two closely 
apposed axonal ends. Such plasmalemmal fusion (PEG-fusion) rapidly (within 
seconds to minutes) restores axonal morphological integrity, axonal conduction 
of action potentials across the lesion site and therefore also rapidly restores 
behavioral functions mediated by severed CNS and PNS axons in invertebrates 
and mammals in vitro and in vivo (Bittner et al., 1986; Borgens & Shi, 2000). 
 We now report the ability of four experimental compounds [melatonin 
(MEL), cyclosporin A, (CsA), glial-derived neurotrophic factor, (GDNF), and 
methylprednisolone, (MP)] to alter the ability to PEG-fuse severed sciatic axons 
in rats compared to PEG-fusion of severed sciatic axons in control Krebs saline 
(CTL) that contains calcium. These experimental compounds were chosen 
because all have been reported to have antioxidant effects and/or to enhance 




      
GDNF= 3.4×10−5 _M, MP= 10_M) (Dumont et al., 2001; Fine et al., 2002). We 
also tested PEG-fusion success when extracellular calcium was removed from 
the CTL (CTL-Ca) in vivo because PEG fusion success in vitro is increased by 
reducing extracellular calcium in similar physiological saline (Lore et al., 1999). 
  
METHODS 
In vitro preparations 
For in vitro preparations, segments of sciatic nerves 3.5 cm in length were 
dissected from the hindlimbs of adult Sprague–Dawley rats (∼200 g) immediately 
after sacrifice by an i.p. injection of sodium pentobarbital (60–80 mg/kg) and an 
injection of saturated KCl into the heart. Dissected sciatic nerve segments were 
incubated for 18 h at 37–38 ◦C under oxygen (95% O2, 5%CO2) in CTL (Krebs 
physiological saline in mM; 124 NaCl, 5 KCl, 1.2KH2PO4, 1.3MgSO4, 26 
NaHCO3, 10Na ascorbate, 10 dextrose, 2 CaCl2, pH 7.35) or CTL containing an 
experimental compound (either CsA, MEL, GDNF, or MP). When testing each 
experimental compound, segments bathed in CTL were always run 








      
 Axonal viability and continuity was determined electrophysiologically by 
removing the nerve segments from the oxygenated, temperature-controlled vials 
and placing them in a 5-chamber sucrose gap recording device as previously 
described (Lore et al., 1999). The central chamber was filled with CTL, the end 
chambers with 0.12M KCl, and the two middle chambers with 0.23M sucrose. 
Compound action potentials (CAPs) were produced by supramaximal stimuli (1/s 
0.4 ms duration, 4.5V pulses) to one end chamber. CAPs were recorded from the 
other end chamber, conventionally displayed on an oscilloscope, and peak CAP 
amplitudes were measured. 
 
PEG-fusion 
 The procedure for PEG-fusion was as follows. CTL was removed from the 
central chamber following the recording of the CAP and replaced with CTL-Ca. 
PEG-fusion was attempted on nerve segments that exhibited a CAP of 1.5mV 
or greater (about four times greater than the smallest CAP that was easily 
detectable) by crushing a 1–2mm portion of the nerve segment in the middle 
chamber with fine forceps until a CAP was no longer detected (Marzullo et al., 
2002). This procedure insured that the crush injury completely severed the sciatic 
axons (Lore et al., 1999).  PEG (2000 Da) obtained from Aldrich (Milwaukee, WI) 
and dissolved in distilled water (50%, w/w) was applied for 2 min to the crush-
injury site in the central chamber, which remained bathed in the applied PEG for 




      
that bathed the injury site in the central chamber was then replaced by washing 
several times with oxygenated CTL. After bathing for 10 min in CTL, the sciatic 
nerve was again stimulated in the end chambers as described above to record 
CAPs conducted across the crush-lesion site following PEG-induced fusion of the 
severed axon ends in the central chamber (Marzullo et al., 2002). Axons severed 
by crush or cut lesions do not conduct CAPS in the absence of PEG application 
(Shi & Borgens, 1999). 
 
In vivo preparations 
 In in vivo preparations, sodium pentobarbital (40 mg/kg) i.p., was used as 
anesthesia, preceded by an injection of atropine (0.5 ml/kg) s.c. When 
supplemental anesthesia was required, halothane was administered by 
inhalation.  An incision ~2.5 cm long was made in the mid-thigh and surgical 
spreaders were used to expose the sciatic nerve, which was cleaned of 
connective tissue, and the sheath nicked. Two pairs of hook electrodes were 
placed under the sciatic nerve, one pair to stimulate and the second to record the 
CAP, which was conventionally displayed on an oscilloscope.  Using Dumont 
forceps (#5), the sciatic nerve was severed (pinched three times) and again 
stimulated to confirm that CAPs were no longer conducted across the lesion site 
A narrow stream of 100_M MEL, 100_M MEL in CTL-Ca (MEL-Ca), 10 _M MP, 
CTL, or CTL-Ca was applied to the lesion site. Next, PEG dissolved in distilled 




      
remain for an additional 2 min. The PEG was then pipetted off the injury site, 
which was washed with CTL. The nerve was again stimulated and recorded 
using hook electrodes to determine if the severed ends had been PEG-fused as 
evidenced by their ability to conduct CAPs >0.4mV across the lesion site.  After 
attempting to record CAPs for approximately 5 min (repositioning the hook 
electrodes if no signal was initially recorded), the rat was euthanized by an 
injection of saturated KCl into the heart.    
All experimental procedures were conducted in accordance with state and 
federal guidelines and with the approval of our institution’s animal care and use 




As previously reported peak CAP amplitudes of ≥0.4mV were easily 
detectable in the sucrose gap chamber (Marzullo et al., 2002).  Peak CAP 
amplitudes were typically 2–11mV prior to PEG-fusion and 0.5–2.0mV after 
successful PEG-fusion.  No CAP was detectable in cases of unsuccessful PEG-
fusion.  Differences in CAP amplitudes were assessed by one-way ANOVA, with 
significance set at p < 0.05. Differences in PEG-fusion percentages were 
assessed by χ2 tests, with significance set at p < 0.05. 
 Electrophysiological viability of sciatic nerve segments maintained at 37–




      
severance by measuring peak CAP amplitudes in the sucrose gap chamber. A 
significantly (χ2 = 11.62, p < 0.025) higher percentage of severed nerve 
segments could be PEG-fused following 18 h exposure to MEL compared to CTL 
(Fig. 1A), as assessed by their ability to conduct CAPs >0.4mV through the 
lesion site after PEG application. Exposure to the other compounds did not result 
in significantly greater percentages of PEG-fusion compared to CTL. 
Furthermore, ANOVA showed significant differences in the fusion CAP amplitude 
across all groups (F[4,73] = 4.95, p < 0.001) with post-hoc assessments 
demonstrating that only MEL produced significantly (p < 0.001) higher CAP 
amplitudes conducted through the lesion site after PEG-fusion compared to CTL 
or any other experimental compound (Fig. 1B). To insure that these CAPs were 
due to repaired axons conducting through the lesion site, PEG-fused sciatic 
segments that displayed peak CAP amplitudes >0.4mV were again crushed 
halfway between the stimulating and recording electrodes by pinching three 
times with #5 Dumont forceps. This re-crushing always eliminated our ability to 
record a CAP conducted across the lesion site. 
 
In-vivo Experiments 
 Given these in vitro data, we examined whether exposure to MEL in vivo 
also significantly increased the ability to fuse sciatic axons following severance, 
compared to CTL or MP (one of the compounds that had no acute effect to 




      
experimental groups indicated that the application of MEL in vivo (Fig. 2) 
produced a significantly higher percentage of PEG-fusions (χ2 = 7.65. p < 0.025) 
than CTL. All these in vitro and in vivo data suggest that MEL has beneficial 
effects to PEG-fuse severed axons. 
 Previous reports have shown that the application of PEG in calcium-free 
salines significantly increases the success of PEG-fusion in vitro (Lore et al., 
1999). The current study shows that CTL-Ca also significantly increases the 
success of PEG-fusion in vivo (compare CTL with CTL-Ca in Fig. 2). When 
nerves were bathed in CTL prior to PEG-fusion, the percentage of fusion success 
was significantly (χ2 = 7.93, p < 0.01) lower than when axons were exposed to 
CTL-Ca prior to PEG-fusion.  However, the ability of MEL to increase PEG-fusion 
success (Fig. 2) is so effective that it appears to overwhelm the effect of the 
absence of calcium in MEL-Ca to enhance PEG fusion. Specifically, there is no 
significantly greater effect of MEl-Ca to enhance PEG-fusion success compared 
to MEL (compare MEL with MEL-Ca in Fig. 2). 
 
DISCUSSION 
 Our data strongly suggest that the effects of MEL to enhance PEG-fusion 
are relevant to both in vitro and in vivo preparations. In contrast, one other 
compound (CsA) that we have found to be efficacious in vivo is not effective in 
vitro, and may only be beneficial in vivo following a 5-day pre-treatment (Sunio & 




      
That is, we have demonstrated that MP, currently the “gold–standard” of 
treatment for injuries to the CNS, has no beneficial effects on axon survival or 
PEG-fusion success either in vitro or in vivo.  Further, MP can have substantial 
negative side effects (Dumont et al., 2001).  In contrast, MEL appears to have 
relatively few, if any, deleterious side effects at the dosage (100 _M) we have 
used to enhance PEG-fusion (Karasek et al., 2002).  PEG-fusion in turn, has 
been shown to rapidly repair severed axons in vitro and in vivo in a variety of 
invertebrate and mammalian species: neurites of mammalian cell lines in culture, 
earthworms, crayfish, rats, and guinea pigs (Bittner et al., 1986; Lore et al., 1999; 
Borgens & Shi, 2000).  Hence, PEG combined with MEL might well be effective 
to rapidly repair severed axons following crush-type injuries to sciatic nerves and 














      
 
 
Fig. 1.1: MEL enhances PEG-fusion (A) and peak CAP amplitude (B) in vitro. (A) 
The percentage of PEG-fusion success of severed sciatic nerve segments 
maintained at 37–38 ◦C in vitro for 18 h post-severance in MEL, CsA, GDNF, MP, 
or CTL. p < 0.025 for MEL vs. CTL and p > 0.05 for all other experimental 
compounds vs. CTL by χ2 analyses and (B) the peak CAP amplitude of severed 
sciatic nerve segments maintained at 37–38 ◦C in vitro are significantly higher in 
those segments exposed to MEL compared to the other compounds, F[4,73] = 
4.95, p < 0.001. n = total number of animals sampled in each treatment group for 
Figs. 1 and 2. For A and B MEL: n = 12, CsA: n = 11, GDNF: n = 19, MP: n = 11, 







      
 
 
Fig. 1.2: MEL or reduced extracellular calcium enhances PEG-fusion in vivo.  
MEL in vivo produces a significantly higher percentage of PEG-fusions compared 
to CTL (χ2 = 7.65. p < 0.025). CTL-Ca enhances PEG-fusion success compared 
to CTL. PEG-fusion success in CTL-Ca was 80% compared to 33% in CTL (χ2 = 
7.93, p < 0.01). There was no significant difference between the two MEL groups 
(MEL, MEL-Ca), probably because of the strong effect of MEL to enhance PEG-





















      
Chapter Two: PEG rapidly restores axonal integrity and improves the 
recovery rate after sciatic nerve crush injury 
 
INTRODUCTION 
 Crush-severance is the most common form of traumatic injury to PNS 
axons in humans (Bozkurt et al, 2007, 2008).  Crush-severance injuries 
completely disrupt the axolemma at the lesion site and also produce smaller 
plasmalemmal holes proximal and distal to the severance site (Bittner et al. 1986; 
Lore et al. 1999).  Distal segments of severed mammalian PNS and CNS axons 
undergo Wallerian degeneration in 12-72 hours (Waller 1850; Ramon y Cajal 
1928).  If proximal PNS axonal segments survive axotomy, regeneration by 
outgrowth can occur at rates of 1-2 mm/day (Ramon y Cajal, 1928; Hadlock 
2005).  Hence, acute (within days) recovery in mammals is non-existent.  Chronic 
behavioral recovery is delayed and often very inadequate or non-existent 
because PNS outgrowths take months-to-years to reach denervated target 
tissues in larger mammals such as humans and those target tissues are often 
non-specifically re-innervated (Das and Wallace 1986; Ingoglia and Murray 2001; 
Bozkurt et al. 2007, 2008).   
In the last several decades, various procedures have improved the 
number and specificity of PNS axons that re-establish connections following 
severance, but not the outgrowth rate or time for PNS axons to re-establish those 
connections.  For example, nerve grafts (Jeng and Coggeshall 1986; Lago et al. 




      
et al. 2007), and nerve growth guides (Aebischer et al. 1990; Kalbermatten et al 
2009) have all been reported to improve the extent of regeneration by severed 
PNS axons, but not the rate or time at which PNS axons re-establish their 
connections.  
We now describe the further use of an unconventional technique to 
improve the time to re-innervate and specificity of acute and chronic repair of 
mammalian PNS axons by directly applying PEG solutions to the lesion site of 
severed axons (Fig. A1.1). 
In the present study, we confirm that PEG applied directly to the lesion site 
rapidly restores morphological and physiological continuity to crush-severed PNS 
axons.  We report for the first time that this PEG-fusion technique rapidly (within 
24 - 48 hours) improves behavioral function in rats with crush-severed sciatic 
axons as measured by a modified foot fault (FF) test (Schallert et al. 2002; Yang 
et al. 2006).  Only behavioral measures in this or any other study reported to date 
indicate whether PEG-fusion or any other technique to enhance regeneration has 
re-connected proximal and distal axonal ends of individual mammalian axons 









      
METHODS 
Animals 
 All experimental procedures were approved by the University of Texas at 
Austin’s Institutional Animal Care and Use Committee.  
 Our experimental group consisted of animals with crush-severed axons 
that receive a PEG treatment. Control groups and their rationales were as 
follows:  Crush-severed controls treated with distilled water examine whether our 
vehicle affects any of our three measures of nerve repair. Sham controls 
examine whether the injuries to skin and adjacent muscles impair any measure 
of nerve repair. Cut-severed controls examine whether any measure of repair 
occurs naturally when a rat sciatic nerve receives a very severe and less 
common injury, in which the ends of proximal and distal sciatic nerve axons 
separate by ~ 2mm and are not surgically re-apposed.   
One set of experimental and control groups totaling 40 adult male 
Sprague-Dawley rats (250-350 g) received in vivo CAP measurements to both 
sciatic nerves (80 nerves total: 18 PEG-crush; 21 crush; 4 distilled water crush; 6 
cut; 31 sham-operated) to assess axonal continuity immediately followed by in 
vitro intra-axonal dye diffusion assessments of axonal continuity (Table 1).  
Another set of experimental and control groups totaling 39 adult male Sprague-
Dawley rats (250-350 g) received in vivo CAP measurements to assess axonal 
continuity of one (left) sciatic nerve (39 nerves: 13 PEG-crush; 9 crush; 9 distilled 




      
eight weeks using two behavioral tests (Table 1).  All animals were housed in 
groups of three in polycarbonate cages with sawdust bedding, maintained on a 
12:12 dark:light cycle and given food and water ad libitum.   
 
Surgical Procedures 
 Rats were anesthetized with intraperitoneal injections of ketamine (90 
mg/kg) and xylazine (10 mg/kg).  An incision about 1.5 cm long was made in the  
hindlimb posterior-thigh muscles to expose the sciatic nerve.  Exposed sciatic 
nerves were bathed with hypotonic Ca2+-free Kreb’s physiological saline 
containing 0.5 mM EGTA (Ca2+-free saline in mM: 99 NaCl, 5 KCl, 1.2 KH2PO4, 
1.3 MgSO4, 26 NaHCO3, 10 Na ascorbate, 10 dextrose, pH 7.35, 295 milli-
osmolar), and cleaned of connective tissue.  Animals in the sham-operated group 
received no nerve injury following exposure of the sciatic nerve via incision.  The 
sciatic nerve was bathed with isotonic Ca2+-containing saline (in mM; 124 NaCl, 5 
KCl, 1.2 KH2PO4, 1.3 MgSO4, 26 NaHCO3, 110Na ascorbate, 10 dextrose, 2 
CaCl2, pH 7.35, 345 milli-osmolar) before closing the incision.  
 Sciatic crush-severance injuries were made with Dumont # 5 forceps.  
Experimenters carrying out the crush were blind to the assignment of post-crush 
treatment to eliminate possibility of bias in the force used to make the crush in 
the PEG vs. non-PEG treatments.  Following crush injury, the severed ends of 




      
epineural sheaths. The epineural sheath of the sciatic nerve was nicked with 
microscissors to allow better access of PEG or other solutions to axonal tissues.   
Experimental animals in the PEG- crush group received a topical 
application of a 50% solution (w/w) of 2 kD PEG dissolved in distilled water 
following crush injury.  PEG was applied from a micropipette positioned so that 
the PEG-containing solution flowed in a narrow stream (about 1 mm wide) over 
the crushed axons at the lesion site and allowed to bathe the injured nerve for 
about 1.5 min.  Control animals in the crush injury group received no further 
treatment.  Control animals in the distilled water crush group received a vehicle 
treatment of distilled water applied as previously described for the PEG-treated 
group.  Control animals in the cut group received a sciatic nerve transection with 
micro-dissection scissors so that the proximal and distal ends retracted for 1-2 
mm and were not re-apposed or further treated, which produced a complete 
severance of all axons and their epineural sheaths.  After assessing CAP 
conduction (see below), the skin incision was closed with staples in all rats that 
later received behavioral tests. 
All experimental and control animals used for behavioral testing received a 
5 mg/kg subcutaneous injection of ketoprofen after surgery.  Pharmacokinetic 
studies show that ketoprofen is almost completely excreted within 24 hours 
(Kantor 1986).  Our first behavioral analysis was conducted at 24 hours post-
operation and therefore ketoprofen should have very little, if any, residual effect 




      
           Fewer measurements were needed in the cut or distilled water control 
groups than originally expected to obtain statistically significant differences 
because there was no variation in CAP amplitude for any control group with cut 
or crush injuries (CAPs were never detected, i.e., were 0 mV). The smaller 
number of rats in cut and distilled water crush treatment groups conducted later 
in this study reflects these observation.  CAP confirmation for PEG-crush animals 
required the conduction of CAPs through the lesion site, and 31 PEG-fused 
sciatic nerves met this criterion.  One PEG-crush sciatic nerve in the behavioral 
PEG-crush treatment group did not meet this criterion and that animal was 
removed from the study.  That is, PEG-fusion was successful in 31 (97%) of 32 
attempts. 
 
Electrophysiological recording of CAPs across a lesion site 
 As one measure of axonal continuity through a lesion site, conventional in 
vivo extracellular stimulation and recording of CAPs (extracellular recordings of 
action potentials generated by sciatic nerve axons) was performed for animals 
(n=40) immediately used to examine morphological continuity by in vitro intra-
axonal dye diffusion (Lore et al. 1999) as well as for animals (n=39) used to 
examine behavioral measures of re-innervation specificity for 8 post-operative 
weeks.  Nickel-tipped hook electrodes were placed beneath the sciatic nerve to 
stimulate and record CAPs, which were visualized on an oscilloscope display.  




      
by recording CAPs of at least 0.5 mV conducted through the site of the proposed 
cut or crush injury.   
After cutting or crushing the sciatic nerve between the stimulating and 
recording electrodes, complete severance of all axons was confirmed by an 
inability to record any detectable CAPs conducted through the lesion site (Lore et 
al. 1999).  After any treatment, the sciatic nerve was always stimulated to 
determine if any detectable CAPs conducted through the lesion site.  During pre-
operative and postoperative CAP recordings, the nerve was frequently moistened 
with Ca2+-free saline.  Some animals received a sham operation consisting of 
exposure of the sciatic nerve via incision and application of Ca2+-containing 
saline.  Since these control animals in a sham-operated group received no neural 
injury, one CAP measurement was taken during each sham operation, and that 
CAP amplitude was plotted as both a pre- and post-operative CAP (see Fig. 2 in 
Results). 
 
Intra-axonal dye diffusion across a lesion site 
 As described above and in Table1, one group of experimental animals 
received crush-severance injury followed by treatment with PEG and other 
groups of control animals received a sham, cut-severance, crush-severance or 
crush-severance injury plus distilled water. The effectiveness of all these 




      
To examine intra-axonal diffusion of dye through the lesion site after 
performing a CAP confirmation assay, we excised a 3-4 cm length of the sciatic 
nerve (including the lesion site) from each animal as described in Lore et al. 
(1999).  We removed most of the epineural sheath and placed the nerve in a 
water-tight well made of Vaseline ejected from a 20 cc syringe on a 60x15 mm 
petri dish.  For all sham operations and crush-severed nerves (PEG-treated, 
distilled water treated, and no treatment), the proximal end of the sciatic nerve 
was placed within the Vaseline well containing Ca2+-free saline and 20 μL of 
hydrophilic dye (Texas red dextran, Molecular Probes).  The remainder of the 
nerve, including the crush site, was bathed in Ca2+-free saline.  For cut nerves, 
two Vaseline wells were made; one well contained the proximal end of the nerve 
bathed in Ca2+-free saline and 20 μL of 15% Texas Red Dextran (Molecular 
Probes), while the distal segment of the nerve was anchored within the second 
well such that the transected segments were 1-2 mm apart.  The petri dishes 
containing nerves in Vaseline wells were refrigerated for 14 hours at 4˚C, and 
usually examined for intra-axonal diffusion of fluorescent dye beyond the crush or 
transection site using a Zeiss ICM-405 inverted fluorescence microscope.  Some 
nerves were imaged using a Leica DM IRBE with a 20X objective outfitted with a 







      
Behavioral tests  
 Behavioral assessments were performed by experienced testers blind to 
the treatment condition during the dark portion of each animal’s daily light cycle 
in which rats are more active.  Animals were handled daily for seven days prior to 
the start of behavioral testing.  After receiving a CAP continuity assay of their left 
sciatic nerves, experimental and control groups of rats were behaviorally 
evaluated at 24, 48, and 72 hours after surgery, and then at weekly post-
operative intervals for 8 weeks.  Animals were first tested at 24 hours post-
operatively to allow animals to recover from anesthesia.  
 
Foot-fault Test 
 Animals were allowed to roam freely on a wire mesh grid (45 cm x 30 cm, 
with 2.5 cm x 2.5 cm openings) elevated 1.5 cm above a solid base floor.  Trials 
for each animal were recorded for 50 total steps per hindlimb.  A foot fault was 
scored when a misstep resulted in the hindlimb falling through an opening in the 
grid.  If the hindlimb misstepped, but was pulled back before touching the floor 
beneath the grid, the movement was scored as a partial fault and given a fault 
score of one.  A full fault occurred when the animal’s hindlimb touched the floor 
beneath the grid for support.  Full faults were given a fault score of two.  A 
composite fault score was calculated (see equations below) for each of the 
injured and uninjured hindlimbs of every animal at each post-operative time.  The 




      
obtain a fault percentage for each hindlimb.  The percentage of faults by the 
injured hindlimb was subtracted from the percentage of faults by the uninjured 
hindlimb, yielding an asymmetry score for each animal at a given post-operative 
time according to the following three equations:  
 
(1)  Composite FF Score = (# Partial Faults x 1) + (# Full Faults x 2) 
(2)  %FF  = Composite FF Score/50 (total number of steps) x 100% 
(3)  FF Asymmetry Score = % FF (uninjured limb) – %FF (injured limb) 
 
FF asymmetry tests were conducted two times at 1-5 days prior to surgery and 
their scores averaged to obtain pre-operative baseline values plotted at 0 post-
operative days.  
 
Sciatic Functional Index  
 Footprints have been used previously to measure gait quality in rat models 
of Parkinson’s disease (Schallert et al. 1978) and sciatic nerve severance by the 
SFI (de Medinaceli et al. 1982).  Rats were trained to traverse a wooden beam 
ending in their home cage. After a few habituation trials, during which rats 
frequently stopped and paused en route to their home cage, rats traversed the 
beam to the home cage without hesitation.  For each trial run, a white strip of 
paper was secured to the wooden beam to collect footprints (two trials per rat at 




      
inked with black and red ink, respectively, and were placed near the end of the 
wooden beam farthest from the home cage.  Three consecutive footprints from 
each limb (for a total of six consecutive prints) were used to measure (in 
millimeters) the following: NPL: normal footprint length; EPL: experimental 
footprint length; NTS: normal toe spread between toes one and five; ETS: 
experimental toe spread; NIT: normal intermediary toe spread between toes two 
and four; EIT: experimental intermediary toe spread (Carlton and Goldberg 
1986).  SFI scores were then computed for each animal at a given post-operative 




SFI scores of about 100 indicate complete impairment of behaviors mediated by 
the sciatic nerve, and scores of about 0 indicate normal use/complete recovery of 
behaviors mediated by the sciatic nerve (de Medinaceli et al. 1982; Mackinnon et 
al. 1989).  SFI tests were conducted three times at 1-5 days prior to surgery and 








      
Statistical Analyses 
 Students’ t-test was used to assess differences (p<0.05) in pre-operative 
CAP amplitudes vs. post-operative CAP amplitudes.  ANOVA was used to 
assess differences in SFI and FF asymmetry scores, and Tukey’s test was used 
for post-hoc analysis to adjust for multiple comparisons. Hindlimb motor 
behaviors were subjected to a linear regression t-test to determine whether the 
regression line slopes of two treatment groups differed significantly (p<0.05) over 
the eight-week observational period following surgery.    
 
RESULTS 
CAP Assessments of Axonal Continuity  
To evaluate the ability of PEG-fused axons to conduct action potentials 
across the lesion site in vivo, we measured pre- and post-injury CAP amplitudes 
for all treatment groups.  Peak CAP amplitudes of ≥ 0.5 mV were easily 
detectable with hook electrodes.   
For dye diffusion experimental and control groups (n = 40 rats, 80 nerves), 
we recorded CAPs in vivo (Fig. 2) from both sciatic nerves, and immediately 
assessed these nerves for morphological continuity by observing intra-axonal 
dye diffusion in vitro (Fig. 2).  As previously described, sham-operated animals 
received no neural injury and only one CAP measurement was taken during each 
sham operation.  Sham-operated CAP data are shown as identical pre-and post-




      
these sciatic nerves ranged from 1-5 mV, and the mean pre-operative CAP 
across all treatment groups was 2.4 ± 0.09 mV. Pre-operative CAP amplitudes 
were not significantly different between treatment groups.  No post-operative 
CAP was detectable immediately following crush injury, cut injury or treatment 
with distilled water following crush injury (Fig. 2). The mean post-operative CAP 
following PEG-fusion of crush-severed axons was 2.0 ± 0.22 mV.  This average 
post-operative CAP was significantly (p<0.005) reduced compared to the pre-
operative CAP amplitude for this PEG-fused group or the average pre-operative 
CAP amplitude pooled for all experimental groups used to assess intra-axonal 
dye diffusion. The observation that the post-operative CAP is 72% or 89% of pre-
operative or control CAPs, respectively, indicates that the two halves of many 
crush-severed sciatic axons are joined by PEG application. 
We also observed pre-operative CAP amplitudes ranging from 1-6 mV 
whose average values were not significantly different between any two groups 
(Fig. 2) in recordings from animals (n = 40) that were subsequently tested for 
behavioral recovery at 24 hours to 8 weeks postoperatively. The mean pre-
operative CAP across all treatment groups was 3.2 ± 0.22 mV (cut n=4; crush 
n=9; distilled water crush n=9; PEG-crush n=13; sham n=4).  CAPs from sham-
operated animals were treated as described above.  CAPs conducted across the 
lesion site were not detected immediately following cut or crush injuries in the 
absence of PEG application.  Crush-severed nerves did not have a detectable 




      
injury, all 32 PEG-treated nerves, except one, had successful PEG-fusion as 
measured by conduction of CAPs of at least 0.5 mV through the lesion site (Fig. 
2).   
The mean post-operative CAP after successful PEG-fusion of crush-
severed sciatic nerves was 1.9 ± 0.23 mV (Fig. 2) and was significantly (p<0.001) 
reduced compared to the pre-operative CAP for this PEG-fused group (2.87 ± 
0.29 mV) or the average pre-operative CAP pooled for all experimental groups 
(3.27 ± 0.36 mV).  The significant reduction in postoperative mean CAP 
amplitude for PEG-treated nerves indicates that not all crush-severed sciatic 
axons are immediately repaired by PEG application.  The observation that the 
post-operative CAP amplitude is 57% or 50% of pre-operative or control CAPs, 
respectively, again indicates that the two halves of many crush-severed sciatic 
axons are joined by our PEG-fusion technique, although the specificity of those 
connections are not tested by this measure. 
 
Intra-axonal Dye Diffusion Assessments of Axonal Continuity  
For one set of experimental and control groups for which in vivo CAPs 
were measured (Fig. 2, black and red bars), we evaluated the morphological 
continuity of axons in the sciatic nerve in vitro by observing the intra-axonal 
diffusion of Texas Red, a hydrophilic fluorescent dye (Fig. 3).  The lesion site was 
readily visible as a distinct gap in low-power fluorescence images.  Small 




      
extra-axonal autofluorescence was sometimes visible in distal nerve segments.  
In all sham (uninjured) nerve segments (n=31, Fig. 3A), the dye was visible intra-
axonally throughout the entire segment (Fig. 3B).  Dye did not diffuse intra-
axonally across the lesion site in any nerves following crush injury (n=21, Fig. 3A, 
C), cut injury (n=6, Fig. 3A, E), or crush injury with distilled water treatment (n=4) 
(Fig. 3A, image not shown).  In contrast, for 17 of 18 total nerves (94%) that were 
crushed and subsequently treated with PEG, dye diffused across the lesion site 
(Fig. 3A, D).  All these CAP and intra-axonal dye data are consistent with the 
interpretation that crush- or cut-severance completely disrupts physiological and 
morphological continuity between axonal segments proximal and distal to the 
lesion site and that PEG application usually rapidly restores physiological and 
morphological continuity to many crush-severed axons.  
 
Foot Fault Asymmetry Scores    
FF asymmetry scores (averages +/- SEM, see Methods) were obtained 
twice for each animal prior to any operative procedures and at post-operative 
times of 24, 48, and 72 hours, and weekly for eight weeks.  We observed no 
significant differences in baseline scores between any experimental groups.  
Sham-operated animals did not show any obvious behavioral deficit as measured 
by FF asymmetry score at any post-operative time, indicating that muscle injury 
during surgery did not produce detectable impairment in hindlimb motor 




      
asymmetry score of -72 +/- 6.5 at 24 hours following surgery, and did not improve 
over the course of the study.  The FF asymmetry scores did not differ 
significantly (p > 0.05) for animals with crush-severed sciatic nerves that received 
no further treatment (n = 9) compared to animals that subsequently received 
distilled water as a vehicle control (n=9, data not shown).  Thus, FF asymmetry 
scores were pooled from crush and crush nerves treated with distilled water (n = 
18).                
PEG-crush animals performed better than crush animals when measured 
at 24 hours after surgery and this difference persisted until post-operative week 
four.  One-way ANOVA showed significant differences in behavior function (as 
measured by FF) across all groups (F [3,24] = 29.4, p < 0.001), with post-hoc 
assessments demonstrating that PEG-crush animals performed significantly 
(p<0.05) better between 24 hours to 3 weeks post-operation compared to crush 
group animals.  At 4-8 weeks after surgery, PEG-crush and crush group animals 
did not differ significantly in their behavior; i.e., recovery was so complete that the 
behaviors of intact PEG-fused and sham-operated animals were 
indistinguishable (p>0.05).  Crush and PEG-crush animals showed improved 
hindlimb motor behavior relative to cut animals at 24 hours following surgery 
(p<0.05).  At 48 and 72 hours post-operation, cut group animals performed 
similarly to crush group animals (Fig. 4).  Crush group animals continued to 
significantly improve relative to cut group animals from 72 hours through eight 




      
better from 24 hours through three weeks post-operation compared to cut, crush, 
and PEG-crush group animals (p<0.01).   
 We also compared the time course of recovery of FF asymmetry scores 
for different groups (lines connecting data points in Fig. 4) by regression analysis 
(see Methods).  The rate of recovery of crush and PEG-crush animals was 
significantly (t [18] = 3.64, p < 0.001; F [13] = 3.69, p < 0.01) faster compared to 
cut group animals, which did not show any improvement for eight weeks post-
operation. The time course of recovery for PEG-crush animals was also 
significantly improved compared to untreated crush animals (t [27] = 2.13, p < 
0.05; Fig. 4). 
  
Sciatic Functional Index  
 Mean SFI scores +/- SEM (see Methods) were obtained three times for 
each animal prior to any operative procedures and at post-operative times of 24 
hours, 48 hours, 72 hours, one week and weekly thereafter for eight weeks (Fig. 
5).  Baseline pre-operative scores did not differ significantly between any 
experimental or control groups.  Sham-operated animals did not show any 
behavioral deficit at any post-operative time as measured by the SFI, indicating 
that muscle injury during surgery did not result in behavioral impairment (Fig 5).  
Cut group animals exhibited a mean SFI score of -92 +/- 0.95, and did not show 
any improvement in behavior for the duration of the study, as previously reported 




      
We observed no significant difference at any post-operative time between 
animals with crush-severed sciatic nerves that received no treatment (n=9) 
compared to animals that received distilled water treatment (n=9; data not 
shown).  These results were consistent with results from electrophysiological 
measures (CAPs: Fig. 2), morphological measures (intra-axonal dye diffusion: 
Fig.3), and FF asymmetry measures (Fig. 4).  Therefore, data from crush and 
distilled water crush group animals were pooled.   
 One-way ANOVA of SFI results showed differences between groups were 
significant (F [3,40] = 18.78, p < 0.001), with post-hoc assessments 
demonstrating no significant difference in the time course of recovery between 
PEG-crush and crush group animals (although further inspection did show that 
PEG-crush animals performed significantly (t [27] = 2.12, p < 0.05) better three 
weeks post-operation compared to crush group animals.  Over the eight week 
post-operative testing period, crush group animals showed significant 
improvement in behavior as measured by the SFI compared to cut group animals 
(p<0.05).  Additionally, sham-operated animals performed significantly better on 
the SFI test than both crush group animals (p<0.01) and PEG-crush animals 
(p<0.01) throughout the study. 
 We compared the time course of recovery of SFI scores for the 
experimental and various control groups (lines connecting data points in Fig. 5) 
by regression analysis (see Methods).  No significant difference was found 




      
PEG-crush animals showed significant (t [18] = 3.35, p < 0.01; t [13] = 3.69, p < 
0.01) improvement in behavior relative to animals with sciatic nerve cuts.   
 
DISCUSSION 
 Assessments of CAP amplitude (Fig. 2) and intra-axonal dye diffusion 
(Fig. 3) show that direct application of PEG to crush-severed sciatic nerves 
usually (97% of all attempts) rapidly restores physiological and morphological 
continuity to at least some axons in the sciatic nerve.  In fact, continuity may be 
restored to many proximal and distal axonal halves (with unknown specificity) 
since CAP amplitudes of PEG-fused nerves on average are 50% to 89% of CAP 
amplitudes of intact-control or sham-operated nerves.  FF asymmetry scores 
(Fig. 4) provide quantitative assessment of hindlimb motor behavior and show 
significantly faster recovery of functional behavior associated with direct 
application of PEG to crush-severed sciatic nerves.  This finding for FF 
asymmetry scores is consistent with our measures of physiological and 
morphological continuity.   
Direct PEG application to crush-severed axons produces significant 
reversal of behavioral deficits within 24 - 48 hours, and does not prevent further 
improvement in behaviors at later (three to eight weeks) post-operative times.  
The shorter-term behavioral recoveries at 24 - 48 hours are likely produced by 
PEG-fused axons.  Longer-term behavioral recoveries at three to eight weeks 




      
and then grew out at 1-2 mm/day to appropriately re-innervate denervated 
muscles.  
 Our data suggesting that PEG-fusion can more rapidly improve behavioral 
recovery following a crush injury to the sciatic nerve in the rat extends previous 
studies indicating that PEG induces both physiological (measured by the restored 
conduction of action potentials through the lesion site) and morphological 
continuity (intra-axonal diffusion of fluorescent dyes across the lesion site) 
between the cut or crushed ends of mammalian myelinated axons (Lore et al. 
1999).  Other recent studies assessing behavioral recovery following PEG 
treatment of cut or crush-severed axons have focused on injury models of CNS 
axons.  Subcutaneous injections of PEG have been reported to partially restore 
the cutaneus trunchi muscle reflex in guinea pigs following a crush injury to the 
midthoracic spinal cord (Borgens and Bohnert 2001).  Rats receiving an 
intravenous injection of PEG following a spinal cord compression injury at T4 
showed improved locomotor performance relative to saline-treated control groups 
as measured by the Basso, Beattie, and Bresnahan open-field hindlimb motor 
scale (Ditor et al. 2007).  A computer-managed open-field behavioral test has 
also been used in a recent study reporting improved exploratory behavior in 
animals receiving a subcutaneous injection of PEG following traumatic brain 
injury compared to untreated animals (Koob et al. 2008).   
The PEG-fusion technique modified for in vivo use may have immediate 




      
severance injuries as measured by physiological, morphological, and behavioral 
assays described herein.  For example, after nerve crush functional recovery is 
often poor if regenerating motor axons are too far from the denervated target 
tissue.  Prolonged denervation of muscle leads to a deterioration of the 
intramuscular nerve sheaths, which are the normal target pathways for 
regenerating motor axons (Mackinnon et al. 1991; Fu and Gordon 1995).  The 
loss of intramuscular nerve sheaths greatly reduces the number of motor axons 
that are able to reinnervate muscle fibers.  In addition, muscle fibers do not fully 
recover from atrophy due to prolonged denervation (Fu and Gordon 1995).  It is 
possible that the repair of at least some axons by PEG-fusion can have a trophic 
integrity-maintenance effect on target muscles that might keep them more 
receptive to reinnervation for a longer time, which could promote a more optimal 
chronic outcome.  That is, initial functional recovery mediated by PEG-fusion of 
some axons might later be increased by reinnervation of denervated muscle 
fibers by newly formed synapses made by other, non-PEG-fused regenerated 
axons that reach the muscle at 4-8 weeks.  
Finally, we have worked on solving a basic problem before now 
considering the clinical use of PEG to repair bundles of crush-severed PNS 
axons (e.g., sciatic or other peripheral nerves).  Severed distal stumps need 
be induced to survive until they can be PEG-fused.  We can now consistently 
(80-100% success rate) induce severed mammalian CNS or PNS axons to 




      
injections of cyclosporin A (Sunio and Bittner 1997) – and such surviving 
axons can be PEG-fused (Lore et al. 1999, Marzullo et al. 2001; Stavisky et 
al. 2003, 2005).  The ability to extend the time needed to use PEG-fusion 
techniques on crush-severed PNS axons is important because such injuries 
usually occur in a non-clinical setting and medical treatment may be delayed 




















      
Dye diffusion groups 
Treatment group 
Number of rats, CAP 
confirmation assays 
PEG-crush 9, 18 
Crush 11, 21 
Distilled water crush 2, 4 
Cut 3, 6 
Sham-operated 15, 31 
 




Number of rats, CAP 
confirmation assays 
PEG-crush 14, 13 
Crush 9, 9 
Distilled water crush 9, 9 
Cut 4, 4 
Sham-operated 4, 4 
 
Total = 40 rats, 39 CAP 
confirmation assays 






      
Table 2.1:  Number of rats and nerves assayed for CAP confirmation of axonal 
continuity for each experimental and control treatment group followed by dye 
diffusion or behavioral assessment.  For sham-operated and PEG-crush groups, 
CAP confirmation was the conduction of CAPs through the lesion site.  For crush, 
distilled water crush, and cut groups, CAP confirmation was the absence of 
CAPs conducted through the lesion site.  Dye diffusion data were collected more 
quickly than behavioral data and both sciatic nerves could be used.  Hence more 
rats were assayed for CAPs and dye diffusion than CAPs and behavior.  
Experimental groups (PEG-crush) and control groups (sham-operated, crush) 
were analyzed in several subgroups to ensure that CAPs did not vary over time 
due to changes in surgical or assay conditions.  That is, there was no significant 
































Fig. 2.2.  CAP amplitudes of rat sciatic nerves recorded pre-operatively (white 
and black bars) and post-operatively (blue and red bars) for each group (cut, 
crush, distilled water-crush, PEG-crush and sham) used in dye diffusion (black 
and red bars) or behavioral (white and blue bars) assays.  Colored bars on the X-
axis indicate a CAP amplitude of 0mV for all animals.  All CAP and other data in 
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Fig. 2.3.  Graph showing percent of sciatic nerve preparations exhibiting intra-
axonal dye diffusion across a lesion site following cut, crush, distilled water 
crush, PEG-crush, or sham operations (Fig. 3A).  Fluorescence images showing 
intra-axonal dye diffusion across a lesion site following B) sham, C) crush, D) 
PEG-crush and E) cut operations in sciatic nerves.  In C and D, dotted lines are 
drawn to show the location and extent of the lesion.  In E, the dotted line 
indicates the edge of the distal segment (not visible because it contained no 
dye).  In each image the proximal portion of sciatic nerve is on the left and the 
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Fig. 2.4.  Mean foot fault asymmetry scores from 0 – 8 post-operative weeks for 
cut (solid line, diamonds), crush (dashed line, circles), PEG-crush (solid line, 
triangles) or sham-operated (dotted line, squares) groups.  Baseline scores were 
obtained twice for each animal prior to surgery and are plotted at the 0 week time 
point.  SEM values are so close to the plotted mean values at some time points 
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Fig. 2.5.  SFI results from 0 – 8 post-operative weeks for cut (solid line, 
diamonds), crush (dashed line, circles), PEG-crush (solid line, triangles) or sham-
operated (dotted line, squares) groups.  Baseline scores were obtained three 
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Chapter 3: Rapid behavioral recovery after axotomy: mechanisms of axonal 
repair by PEG and methylene blue 
 
INTRODUCTION 
Cut- or crush-severed peripheral nerves are common injuries in humans 
that often produce significant behavioral deficits. Severed distal axonal segments 
in mammals degenerate within 1-3 days, and functional recovery involves 1-2 
mm/day axonal outgrowths from surviving proximal stumps that often only 
partially and non-specifically re-innervate distal target tissues. Denervated target 
tissues may permanently atrophy before slowly regenerating motor axons reach 
them weeks-to-years post-operatively in large mammals (Ramon y Cajal, 1928; 
Lago et al., 2007; Bozkurt et al., 2008; Campbell, 2008; Kalbermatten et al., 
2009). Consequently for over a century, improving the rate and extent of 
mammalian axonal regeneration has been a major research goal for many 
neuroscientists, with all repair strategies to date, including nerve grafts, nerve 
growth guides, and microsutures, relying on axonal outgrowths to re-innervate 
target tissues. Such techniques have slightly improved the number and specificity 
of regenerating axons, but never the time course of behavioral recovery (Lago et 
al., 2007; Kalbermatten et al., 2009) – or prevented Wallerian degeneration of 
severed distal axons.   
After injury, mammalian axons that do not repair plasmalemmal damage 




      
Nguyen et al., 2005), much less regenerate, i.e., repair of plasmalemmal damage 
can be neuroprotective.  Plasmalemmal sealing of small holes or complete 
axonal transections in mammalian neurons and other eukaryotic cells is normally 
produced by a Ca2+-induced accumulation of membrane-bound structures 
(mostly vesicles) mediated by various protein isomers, many of which are Ca2+-
dependent and involved in membrane fusion at synapses or the Golgi apparatus 
(Appendix, Fig.A2). Antioxidants (melatonin: MEL) have been reported to 
decrease plasmalemmal sealing (Spaeth et al., 2010) and slightly improve 
behavioral recovery (methylene blue: MB) after damage to nerve or other tissues 
(Zhang et al., 2006; Rojas et al., 2009).  Additionally, recent studies have shown 
that pretreating mice with MB significantly reduced cochlear damage from 
intense broad-band noise (Park et al., 2014).  
In contrast to the slow and incomplete repair of severed mammalian 
axons, for many invertebrates complete behavioral function is often restored 
quickly (within days) after axonal severance because regenerating proximal 
outgrowths need grow only a few mm to specifically fuse with (or otherwise 
activate) their surviving distal axon that does not degenerate for weeks to years 
(Hoy et al., 1967). The membrane fusogen polyethylene glycol (PEG) has also 
been used to rapidly (1-2min) and specifically reconnect (PEG-fuse) the severed 
proximal and distal halves of individually-identified invertebrate giant axons in 
vitro, as measured by intra-axonal dye diffusion, restoration of action potential 




      
their specific behavioral functions in vivo (Krause & Bittner, 1990; Lore et al., 
1999). PEG has also been used to rapidly restore morphological and 
physiological continuity in vitro, ex vivo and in vivo to cut- or crush-severed 
mammalian sciatic and spinal axons (Lore et al., 1999; Marzullo et al., 2002; 
Stavisky et al., 2005; Britt et al., 2010). This PEG-fusion technique has recently 
been used to significantly (but modestly) improve behavioral deficits due to crush 
(but never cut) severance injuries of rat sciatic nerves at 2-3 weeks, but not 
earlier (Britt et al., 2010). 
We now describe for the first time well-specified PEG-fusion procedures 
and their rationale that rapidly and dramatically repair both cut- severed (Fig. A3) 
or crush-severed rat sciatic nerves (Fig. A1) to permanently restore well-studied 
behavioral functions and prevent Wallerian degeneration of many axons.  In brief, 
completely severed sciatic axons are first treated with Ca2+-free hypotonic saline 
to increase axoplasmic volume, open any sealed axonal ends, expel vesicles-
and closely appose crush-severed ends remaining within endo-, peri- or 
epineural sheaths.  Microsutures through epineural sheaths closely appose cut-
severed ends.  MEL or MB is applied to inhibit vesicle formation and decrease 
sealing probability before applying PEG to artificially induce closely-apposed 
membranes of severed, open, vesicle-free axonal ends to flow into each other 
(Lentz, 2007), producing a partial rejoining of the plasmalemmal membranes of 
proximal and distal axonal segments of unknown specificity. PEG-fused axons 




      
seal any remaining holes near the lesion site. Such PEG-fused axons exhibit 
morphological continuity (assessed by intra-axonal dye diffusion) and 
electrophysiological continuity (assessed by conduction of action potentials) 
across the lesion site. These PEG-fusion protocols for cut- or crush-severed 
sciatic nerves rapidly, more completely (40-60% at 24-72 hours after surgery), 
and permanently restore sciatic-mediated behaviors compared to non-treated or 
conventionally-treated animals, as assessed by two standard behavioral tests: 
Sciatic Functional Index (SFI) and Foot Fault (FF).  
We have also examined possible cellular/molecular mechanisms by which 
MB and PEG produce behavioral recovery.  Our in vitro and ex vivo data suggest 
that plasmalemmal leaflets at severed ends of rat hippocampal B104 cells or 
excised sciatic nerves collapse and fuse within seconds when treated with PEG 
(PEG-seal, Fig.A4). Such PEG-sealing is not affected by substances that affect 
previously-reported sealing pathways (Spaeth et al., 2010) and may have 
neuroprotective effects. 
METHODS  
All experimental procedures were approved by the University of Texas at 
Austin’s Institutional Animal Care and Use Committee. All animals were housed 
in groups of three in polycarbonate cages with sawdust bedding, maintained on a 
12:12 dark:light cycle and given food and water ad libitum. 
 




      
 Rats were anesthetized with intra-peritoneal injections of ketamine (90 
mg/kg) and xylazine (10 mg/kg). The sciatic nerve was exposed by an incision 
about 1.5 cm long in posterior-thigh muscles of the hind limb. All exposed sciatic 
nerves were cleaned of connective tissue and bathed with hypotonic Ca2+-free 
Kreb’s physiological saline perfused from a Pasteur pipette. This hypotonic Krebs 
solution Ca2+-free saline contained (in mM) 0.5 EGTA, 99 NaCl, 5 KCl, 1.2 
KH2PO4, 1.3 MgSO4, 26 NaHCO3, 10 Na ascorbate, 10 dextrose, pH 7.35, 295 
mOsm). We confirmed in anesthetized animals that exposed, intact sciatic 
nerves in this hypotonic Ca2+-free saline conducted action potentials across the 
site of any intended lesion (see below).   
Animals in the Sham group received no nerve injury following exposure of 
the sciatic nerve via a skin incision.  
Animals in cut-severance treatment groups received a sciatic nerve 
transection with microdissection scissors so that the proximal and distal ends 
retracted for 1–2 mm, completely severing all axons and their endo-, peri- and 
epi-neural sheaths. The cut severed ends separated by 1-3mm as viewed 
through a 20-50x dissecting microscope. For groups treated with microsutures, 
proximal and distal nerve segments were surgically re-apposed with 10-0 vinyl 
microsutures (S&T).  The microsuture needle was carefully inserted through the 
epineural sheath using a microneedle holder to avoid further damage to the 
axons. Approximately 6-8 microsuture knots were tied during any suture repair. 




      
and/or PEG could be more easily delivered to the axons during the repair. 
Throughout this procedure, the nerve was moistened with hypotonic Ca2+-free 
saline perfused from a Pasteur pipette as described below. 
Sciatic crush-severance injuries were made with Dumont #5 forceps, 
applying enough force to sever every axon. The crush-severance site of the 
sciatic nerve was much less opaque than adjacent uninjured sites viewed at 20-
50x through a dissecting microscope. Following crush injury, a gap of about 1mm 
was visible at the crush site.  After crushing, the sciatic nerves were again 
assessed for CAP conduction across the lesion site. If any CAP was detected, 
the nerve was crushed again. This condition occurred only 2 times out of over 
185 crush-severed nerves.  
To apply treatment solutions, the epineurial sheath of the sciatic nerve 
was nicked at the lesion site with microdissection scissors to allow better access 
of solutions containing PEG (Sigma-Aldrich), MB (Faulding, Aguadilla, PR), 
and/or MEL (Sigma-Aldrich) to cut- or crush-severed axons. For animals in 
groups treated with MB, MEL and/or PEG, 100µM MB or 2mM MEL dissolved in 
ddH2O was applied from a micropipette positioned several mm above the lesion 
site in the sciatic nerve so that a solution flowed in a narrow stream (about 1 mm 
wide) over the cut or crushed axons at the lesion site. The constantly flowing 
solution was applied for 1-2min. Treatments of 500mM PEG dissolved in ddH2O 
were applied to the lesion site via a similar micropipette so that the denser PEG-




      
(if any) were applied before PEG solutions. After any such treatments, a second 
Pasteur pipette was used to bathe the sciatic nerve with isotonic Ca2+-containing 
Krebs saline (in mM; 124 NaCl, 5 KCl, 1.2 KH2PO4, 1.3 MgSO4, 26 NaHCO3, 
110Na ascorbate, 10 dextrose, 2 CaCl2, pH 7.35, 345 mOsm). The skin over the 
lesion site was closed with surgical staples in all rats that later received 
behavioral tests. All animals used for behavioral testing received a 5mg/kg 
subcutaneous injection of ketoprofen after surgery. The effects of the anesthesia 
lasted about 24 hours. 
 A 2-3cm length of sciatic nerve was removed for ex vivo assays of 
morphological integrity by intra-axonal dye diffusion.   
 
Treatment groups and their rationale  
Rat sciatic nerves (n=120 total; see Table S1 for detailed listing of n 
values for each treatment group) assayed in vivo or ex vivo were cut-severed 
(Cut group). Some were left untreated (Cut), some were treated with 
microsutures only (Cut+Suture) to closely appose proximal and distal ends, and 
some were treated with MB only (Cut+MB) or PEG only (Cut+PEG). Some cut-
severed sciatic nerves were treated either with microsutures and PEG 
(Cut+Suture+PEG), or microsutures and MB (Cut+Suture+MB) and others were 
treated with microsutures, PEG and MB (Cut+Suture+MB+PEG). The sham 
group received an incision to expose the sciatic nerve whose epineurium was 




      
group was used as the intact nerve group to which all other treatments were 
compared for complete recovery. Sciatic nerves with cut-severed axons that did 
not receive any treatment (Cut group) were used to assess both the extent of the 
injury and any spontaneous recovery that might occur following injury. All treated 
groups were compared to the cut group to assess possible behavioral recovery. 
Sciatic nerves with cut-severed axons whose cut ends were closely apposed with 
microsutures (Cut+Sutures) were used to compare the effect of a standard 
clinical treatment to untreated cuts (Cut group) and to the effects of several PEG 
protocols (Cut+Suture+PEG and Cut+Suture+MB+PEG).   
Rat sciatic nerves (n= 180 total; see Table S1 for detailed listing of n 
values for each treatment group) assayed in vivo or ex vivo were crush-severed 
(Crush group). Some were left untreated, some were treated with either MEL 
(Crush+MEL) or MB (Crush+MB), some were treated with PEG (Crush+PEG), 
and some were treated with PEG together with MEL (Crush+MEL+PEG) or MB 
(Crush+MB+PEG). Other rats (sham-operated) received an incision to expose 
the sciatic nerve whose epineurium was nicked, but received no crush-severance 
injury or drug treatment. The intact nerves of this sham group were used as the 
control group to which all other treatments were compared for complete recovery. 
Sciatic nerves with crush-severed axons that did not receive any treatment 
(Crush) were used to assess both the extent of our sciatic nerve injury and any 
spontaneous recovery that might occur following that injury. All treated groups 




      
recovery. Sciatic nerves with crush-severed axons treated with PEG only 
(Crush+PEG) were used to compare the effects of those treated with PEG plus 
either MEL (Crush+MEL+PEG) or MB (Crush+MB+PEG). 
Note in all cases the order of CAP or behavioral recovery is almost always 
that given in the key to symbol usage in Figure 1. The order of decreasing 
recovery for cut treatments is: (1) Sham, (2) Cut+Suture+MB+PEG, (3) 
Cut+Suture+PEG, (4) Cut+Suture. Furthermore, Cut+PEG and Cut+MB show no 
improvement compared to cut alone. That is, PEG, MB, and MEL have no 
significant effect unless applied under a well-specified PEG-fusion protocol. The 
order of decreasing recovery for crush treatments is: (1) Sham, (2) 
Crush+MB+PEG,  (3) Crush+MEL+PEG, (4) Crush+PEG. Furthermore, 
Crush+MEL and Crush+PEG show no improvement compared to crush alone. 
    
Electrophysiological recording of CAPs   
Electrophysiological recording of CAPs from each rat sciatic nerve across 
a lesion site in vivo was followed by ex vivo intra-axonal dye diffusion 
assessments of morphological integrity. Two pairs of nickel-tipped hook 
electrodes were placed on or beneath the sciatic nerve to stimulate and record 
CAPs, which were displayed conventionally on an oscilloscope. Any lesions were 
made between the stimulating and recording pairs of hook electrodes. Complete 
crush- or cut-severance of all axons was confirmed by an inability to record a 




      
stimulated after any treatment to determine if CAPs conducted through the lesion 
site. During pre-operative and post-operative CAP recordings in vivo, the nerve 
was often moistened with Ca2+-free saline.  
To correlate a measure of electrophysiological continuity with a measure 
of morphological continuity, we recorded CAPs from both left and right sciatic 
nerves in adult male Sprague-Dawley rats (250-350g) assigned to each of the 
Crush and Cut treatment groups described above. Following all such treatments, 
we assessed morphological continuity with an intra-axonal dye diffusion assay 
(see description in following section).  
In another set of rats, to correlate our measure of electrophysiological 
continuity with our measures of behavioral recovery for each rat, we recorded 
CAPs from the left sciatic nerves before and after any injury and/or subsequent 
treatment. We then post-operatively tested the rats behaviorally for six (FF) or 
twelve weeks (SFI). To reduce use of animals for three crush treatment groups 
(Crush, Crush+MEL, Crush+MB), data were examined for animals previously 
reported (Britt et al., 2010) and additional animals sampled thereafter. Since the 
previously reported versus more recently collected CAP, SFI and FF means did 
not differ significantly (p < 0.05) for any of these three treatment groups, we 
combined the respective data for these groups to generate Figure 3.1. No 
animals in cut treatment groups used any previously reported data. Our CAP 
data are first describing through-conduction for successful PEG-fusion after cut-




      
 
Behavioral Tests  
 Behavioral assessments were performed by experienced testers blind to 
treatment conditions, during the dark portion of each animal’s daily light cycle 
during which rats are more active. Rats were handled daily for seven days prior 
to the start of behavioral testing. Baseline behavior scores for SFI and FF were 
obtained 1-2 days prior to surgery. After surgery, all rats were evaluated for 
behavioral recovery at 24, 48, and 72 post-operative hours and then at weekly 
intervals for 12 weeks (SFI) or 6 weeks (FF). Animals were first tested at 24 post-
operative hours to allow them to recover from most effects of surgery and 
anesthesia that would affect behavioral measures.  
 
Sciatic Functional Index (SFI)   
 The SFI uses footprints to measure gait quality, adapted from rat models 
of Parkinson’s disease (Schallert et al., 1978), and sciatic nerve severance (de 
Medinaceli, 1982; Britt et al., 2010). Such measurements indicate how well 
sciatic axons innervate more distal muscle groups (Britt et al., 2010). Rats were 
trained to traverse a wooden beam positioned to lead up to their home cage. 
After a few habituation trials, during which rats frequently stopped and paused en 
route to their home cage, rats traversed the beam to the home cage without 
hesitation. For each trial run, a white strip of paper was secured to the wooden 




      
baseline and post-operative trials, rats always had their left (surgically operated) 
and right (uninjured) hind paws inked with black and red ink, respectively, and 
were placed near the end of the wooden beam farthest from the home cage. 
Three consecutive footprints from each limb (for a total of six consecutive prints) 
were used to measure (in millimeters) the following: normal footprint length 
(NPL); experimental footprint length (EPL); normal toe spread between toes one 
and five (NTS); experimental toe spread (ETS); normal intermediary toe spread 
between toes two and four (NIT); and experimental intermediary toe spread 
(EIT). Baseline and post-operative SFI scores were then computed for each 
animal as previously described (Schallert et al., 1978; de Medinaceli, 1982). 
 
Foot Fault (FF) Test  
 Compared to SFI scores, foot fault scores indicate how well sciatic axons 
innervate more proximal muscle groups (Britt et al., 2010). Following sciatic 
nerve damage, more proximal muscle groups are expected to be innervated 
before more distal muscle groups (Bittner et al., 2000). Animals were allowed to 
roam freely on a wire mesh grid (45x30cm2, with 2.5x2.5cm2 openings) elevated 
1.5cm above a solid base floor. Baseline and post-operative trials for each 
animal were recorded for 50 total steps per hindlimb. A foot fault was scored 
when a misstep resulted in the hindlimb falling through an opening in the grid. If 
the hindlimb misstepped, but was pulled back before touching the floor beneath 




      
one. A full fault occurred when the animal’s hindlimb touched the floor beneath 
the grid for support and was given a fault score of two. Baseline and post-
operative foot fault asymmetry scores were then calculated as previously 
reported (Britt et al., 2010).   
 
RESULTS 
First, we confirm in anesthetized rats that exposed, intact sciatic nerves 
conduct action potentials across the site of any intended lesion. We then bathe 
the nerves in Ca2+-free hypotonic saline and completely cut-sever them using 
microdissection scissors or completely crush-sever them using fine-forceps. 
Complete cut- or crush- severance is demonstrated by confirming that sciatic 
axons do not conduct action potentials across the severance site and that cut-
severed sciatic nerves have no physical connections between cut ends. Cut-
severed nerves are re-apposed by microsutures. Then, 2mM MEL or 100µM MB 
dissolved in Ca2+-free hypotonic saline is applied to the injury site for 1-2 min. 
Next, 500mM 3kDa PEG in Ca2+-free double distilled water (ddH20) is applied for 
1-2min. Finally, PEG-fused axons are bathed with isotonic Ca2+-containing 
physiological saline to initiate sealing of any remaining axolemmal disruptions. 
 
Intra-axonal diffusion of fluorescent dye in intact and PEG-fused nerves 
To assess morphological continuity ex vivo, we used conventional (Lore et 




      
assessments of intra-axonal diffusion of Texas Red dye. We excised 1-2 cm 
lengths of sciatic nerves on either side of the lesion site from rats in each sham-
operated, cut- or crush-severed treatment group. The most- proximal excised 
end was placed in a watertight Vaseline well containing dye (Texas Red dextran) 
dissolved in Ca2+-free hypotonic saline or Ca2+-containing isotonic saline. The 
lesion site was outside the well and maintained in Ca2+-containing isotonic saline.  
Dye always diffused intra-axonally throughout the entire length of axons 
inside and outside the well when: (1) proximal cut ends were maintained in the 
well in Ca2+-free hypotonic saline in sham-operated animals, (2) cut-severed 
axonal ends were first closely apposed with microsutures and then treated with 
PEG (3) crush-severed axons were treated with PEG. Dye never diffused intra-
axonally throughout the entire length of axons inside and outside the well when: 
(1) proximal cut ends of sham or any treatment group were maintained in Ca2+-
containing isotonic saline or first PEG-sealed, (2) proximal cut ends were 
maintained in Ca2+-free hypotonic saline, but PEG was not applied to crush-
severed nerves or to cut-severed nerves whose cut ends were not closely 
apposed by microsutures. 
These intra-axonal dye-diffusion data as a measure of morphological 
continuity of some PEG-fused axons at the lesion site are consistent with 
conclusions that: (1) Ca2+ prevents dye uptake ex vivo because it initiates sealing 
of severed axonal ends; (2) Ca2+-free hypotonic saline opens axonal ends and 




      
morphological continuity; (3) Cut- or crush- severance completely disrupts axonal 
continuity between proximal and distal axonal segments; (4) If severed axonal 
ends of unknown specificty are open and in close apposition, solutions containing 
PEG can restore morphological continuity to many severed sciatic axons. 
 
Conduction of action potentials in intact and PEG-fused nerves  
To assess physiological continuity of sham-operated or cut- or crush-
severed axons (n>300), we extracellularly stimulated and recorded the ability of 
sciatic axons to conduct compound action potentials (CAPs). We used two pairs 
of hook electrodes, one pair to stimulate and the other to record CAPs on an 
oscilloscope. All cut- or crush-severance lesions were made between the two 
electrodes. Figure 1A and SI Appendix, Table S2 give CAP amplitude data 
recorded in vivo from cut-severed sciatic nerves used for ex vivo dye diffusion 
studies (Dye) and for in vivo behavioral studies (Beh). CAPs were always 
detected in all intact sciatic nerves and never detected across the lesion site 
immediately after cutting the sciatic nerve. CAPs were subsequently detected 
post-cut only for Sham, Cut+Suture+PEG and Cut+Suture+MB+PEG-treated 
nerves, i.e., only when cut nerves were PEG-fused. Cut+Suture+MB+PEG-
treated nerves had the greatest recovery of post-cut CAP amplitudes of any 
treatment group (p<0.001). CAPs were never detected post-cut across the lesion 
site for Cut-, Cut+PEG-, Cut+Suture, Cut+Suture+MB-treated sciatic nerves, i.e., 




      
across the lesion was also always associated with the presence or absence, 
respectively, of dye diffusion across the lesion site.  
Figure 3.1B shows CAP amplitude data recorded in vivo from crush-
severed sciatic nerves subsequently used for ex vivo dye diffusion studies (Dye) 
or from nerves subsequently used for in vivo behavioral studies (Beh). CAPs 
were always detected in all intact axons prior to crushing the entire sciatic nerve. 
CAPs were rarely detected distal to the lesion after crushing the entire sciatic 
nerve. In those rare cases (2/185) when a CAP was detected distally after a 
crush, the nerve was completely crushed again at the same site. CAPs were then 
never detected. CAPs were  always detected post-treatment in the Sham group 
and across the lesion site in Crush+MEL+PEG-, Crush+MB+PEG- and 
Crush+PEG-treated nerves, i.e., if crush-severed ends were PEG-fused. CAPs 
were never detected post-operatively across the lesion site in Crush-, 
Crush+MEL-, or Crush+MB-treated sciatic nerves, i.e., if PEG was not applied. 
Treatment with MB+PEG again produced by far the greatest (73%-78%, p<0.05-
0.001) post-lesion recovery of CAP amplitude for any crush-severed treatment 
group.  CAP data from crush-severed nerves again correlated perfectly with dye 
diffusion data, i.e. the presence or absence of CAP conduction across the lesion 
site was always associated with the presence or absence, respectively, of intra-






      
Behavioral recovery of cut-severed nerves 
To assess the restoration of sciatic mediated behaviors after complete cut-
severance, we used two conventional behavioral assays: the Sciatic Functional 
Index (SFI) and a modified Foot-Fault (FF) asymmetry test. The SFI is more 
sensitive to more distal sensory-motor functions and the FF is more sensitive to 
more proximal sensory-motor functions and earlier behavioral recovery following 
sciatic nerve cut- or crush- severance (Britt et al., 2010).  
One-way ANOVA and post-hoc analyses of SFI data (Fig. 3.1C) showed 
that each data point for the Cut+Suture+MB+PEG group was significantly 
(p<0.01) greater compared to each data point at the same post-operative time for 
all other treatment groups (except Cut+Suture+PEG) from 1-12 weeks post-
operation. Although no pair of data points at a given post-operative time were 
significantly different, curve-fit analyses showed that SFI behavioral recovery for 
the Cut+Suture+MB+PEG group was significantly (p<0.01) greater and faster 
than the 1 day-12 weeks recovery of the Cut+Suture+PEG group, and p<0.001 
when compared to any other cut-severance group. In contrast, curve-fit analyses 
showed no significant difference between Cut+Suture+MB+PEG animals 
operated upon by CPK or JMB (Fig. 3.1C), i.e., successful PEG-fusion is 
possible for researchers with very different training. The Cut+Suture+PEG curve 
was also significantly (p<0.01) better than the Cut+Suture curve (Fig. 3.1C). 
Similar analyses of FF cut-severance groups (Fig. 3.1E) showed that each 




      
p<0.01) greater compared to each data point at the same post-operative time for 
any other treatment group (except Cut+Suture+PEG) from 1-12 weeks post-
operation. Although no pair of data points at a given post-operative time were 
significantly different, comparison of curve-fit parameters revealed the FF 
behavioral recovery for the Cut+Suture+MB+PEG group was significantly 
(p<0.01) greater and faster than the 1day-12 week recovery of the 
Cut+Suture+PEG group, and p<0.001 compared to any other group.  
 For either SFI or FF tests, data for Cut, Cut+MB, or Cut+PEG groups did 
not differ significantly at any time point or for the curves generated by the entire 
set of data points for each group. That is, in the absence of close apposition of 
cut ends, neither MB nor PEG had a beneficial effect. Furthermore, we observed 
no significant difference between Cut+Suture and Cut+Suture+MB. That is, with 
close apposition of cut ends by microsutures, but no PEG-fusion, the anti-oxidant 
MB did not enhance behavioral recovery.  Cut+Suture treatment showed some 
limited and slow improvement compared to Cut alone (p<0.05), as previously 
reported (Bozkurt et al., 2008; Campbell, 2008). Unlike the comparable crush-
severance groups (Crush+PEG and Crush+MB+PEG) described below, FF 
scores for Cut+Suture+MB+PEG or for Cut+Suture+PEG) did not recover to 
levels recorded for sham-operated or intact sciatic nerves. However, our 
Cut+Suture+MB+PEG protocol for PEG-fusion of completely cut nerves did 




      
by the SFI, i.e., 60%-80% within 6-12 weeks compared to 0-25% recovery for Cut 
or Cut+Suture protocols (Fig. 3.1C). 
 
Behavioral recovery of crush-severed nerves 
One-way ANOVA and post-hoc analyses of SFI data (Fig. 3.1D) showed 
that Crush+MB+PEG groups had significantly (p<0.05 or p<0.01) greater and 
more rapid recovery at each post-operative time point compared to all other 
groups (except Sham) from 3 days-2 weeks post-operation. Crush+MB+PEG and 
Crush+MEL+PEG groups had significantly (p<0.01) improved SFI performance 
during post-operative weeks 4-6 compared to those groups treated only with 
PEG.  
 Similar analyses of crush-severance FF data (Fig. 3.1F) showed that 
Crush+MB+PEG groups had significantly greater and more rapid recovery at 
1day-3weeks post-operation compared to Crush+PEG and Crush+MEL+PEG 
(p<0.05) and Crush, Crush+MEL, and Crush+MB (p<0.01) groups. At 4-6 weeks 
post-operation, Crush+MEL+PEG and Crush+MB+PEG groups did not differ 
significantly (p>0.05) in their FF score compared to the Sham group. For either 
SFI or FF tests, data for Crush, Crush+MB, and Crush+MEL groups did not differ 
significantly at any time point or for the curves generated by the entire set of data 
points for each group, i.e., in the absence of PEG-fusion, these anti-oxidants did 
not enhance behavioral recovery.  Recovery after crush injury was much more 




      
scores for cut- or crush- severance groups having successful PEG-fusion were 
always in the order from highest to lowest: MB (or MEL)+PEG treatment then 
treatment by PEG alone which, in turn, was much better than any treatment 
lacking PEG-fusion. 
We have also examined over 15 cut- or crush-severed nerves that were 
PEG-fused at 1-12 weeks post-operatively in sacrificed animals and noted that 
CAPs always transmitted, and dye always diffused, across the lesion site. 
Viewed with a dissecting microscope, the distal portion of the sciatic nerve was 
not obviously different from sham-operated or un-operated nerves, i.e., PEG-
fusion prevented much Wallerian degeneration. 
 
Cellular mechanisms of PEG-sealing and PEG-fusion 
 To begin to examine cellular mechanisms by which PEG, MB, MEL or 
other substances might influence membrane dynamics that affect PEG-fusion in 
vivo, we examined their effect on PEG-sealing in vitro of individually identified 
B104 cells transected >50 µM or <50µM from their soma in Petri dishes (Spaeth 
et al., 2010). Sealing probability was defined as the percent of B104 cells that 
exclude 3kDaTexas Red dextran. Sealing probabilities at each sampling time 
were compared for different treatments using a Cochran-Mantel-Haenszel χ2 test 
(CMH) (Agresti, 1996); sealing rates for different treatments were compared 




      
Since MB and MEL increase PEG-induced behavioral recovery in vivo, we 
first investigated the in vitro effects of 2mM MEL or 100µM MB on sealing of 
B104 cells with transected neurites. After 10 min transection in Ca2+-free saline 
containing MEL or MB, the bathing solution was replaced with Ca2+-containing 
saline (without MEL or MB). At various times after Ca2+ addition (post-Ca2+ 
addition time: PC time), Texas Red dextran dye was added and sealing 
assessed. Sealing probabilities and rates were significantly (p<0.01, CMH; 
p<0.05, FZT) decreased when B104 cells were transected in 2mM MEL or 
100µM MB compared to cells transected in only Ca2+-free saline (Fig. 3.2A,B). 
These effects of MEL and MB on plasmalemmal sealing were similar to the 
effects produced by other antioxidants (Spaeth et al., 2010) 
To examine the effect of PEG on plasmalemmal sealing in vitro, we 
transected B104 neurites >50µm or <50µm from the cell body in Ca2+-free saline 
and added various PEG concentrations for 1min to mimic our PEG application in 
vivo or ex vivo . Texas Red dextran (3kDa) was then added and dye uptake 
immediately (0min post-PEG) assessed. Sealing probability at 0min post-PEG 
increased sigmoidally from 0% to 100% sealing with PEG concentration (R2 
goodness of fit values > 0.97) when B104 neurites were exposed to 0.2-50mM 
PEG for 1min, and then maintained in Ca2+-containing or Ca2+-free saline (Fig. 
3.2C). At lower concentrations (0-0.8mM), PEG did not induce sealing of cut 




      
500mM PEG and uninjured cells also filled with dye (Fig. 3.2C). Similar data 
were obtained for B104 cells transected <50µm from the cell body.  
Our ex vivo data also suggest that PEG can seal or disrupt the 
plasmalemma depending on concentration and duration of PEG application. For 
example, 1-2min applications of lower PEG concentrations in vitro produced 
PEG-sealing (Figs. 3.2C; 3.3A) and shorter application times in vivo or ex vivo 
produced PEG-fusion (Figs. 3.1, 3.3D). In contrast, higher concentrations on 
B104 cells in vitro (Fig. 3.2C) or longer application times on rat sciatic nerves ex 
vivo had deleterious effects (Fig. 3.3D). 
Taken together, these data suggest that (1) PEG rapidly seals (PEG-
seals) plasmalemmal damage in the absence of Ca2+; (2) Sealing probability 
increases as PEG concentration increases up to 50mM PEG; and, (3) Higher 
PEG concentrations rapidly produce plasmalemmal damage.   
Our in vitro PEG-sealing data described above also suggest that PEG 
concentrations of about 50mM most effectively and rapidly reconnect (PEG-fuse) 
crush-severed axonal halves in vivo.  In our in vivo protocol, we use a 
microelectrode to apply 500mM PEG that is then diluted, perhaps to about 
50mM, by extracellular and intracellular fluids between the microelectrode and 
the severed axons several millimeters away.  
To examine the effects of Ca2+ on PEG-sealing, B104 neurites were 
transected in Ca2+-free saline and then treated with 10mM PEG (Fig.3A). These 




      
at 0-5min post-Ca2+ addition (PC) time compared to cells not treated with PEG 
and maintained in Ca2+-containing saline. B104 cells do not usually seal in Ca2+-
free saline (Spaeth et al., 2010), but PEG-sealing of B104 cells occurred as 
rapidly as sealing measurements could be made in Ca2+-free or Ca2+-containing 
saline (Figs. 3.2A-B, 3.3A). However, PEG cannot substitute for all effects of 
Ca2+, since sealing probability declined in transected (or intact) cells never 
exposed to Ca2+, starting 20min after 10mM PEG exposure in Ca2+-free saline 
(Fig. 3.3A).   
To examine whether PEG-sealing utilizes any previously reported 
pathways for membrane fusion in eukaryotic cells, we transected B104 cells in 
various substances at concentrations shown to significantly affect plasmalemmal 
sealing (Fig. 3.3C): N-ethylmaleimide (NEM) to inhibit the N-ethylmalemide 
sensitive factor (NSF), botulinum neurotoxin type A (BoNT A) to inhibit soluble N-
ethylmaleimide sensitive factor attachment protein of 25kDa (SNAP-25), tetanus 
toxin (TeNT) to inhibit synaptobrevin, brefeldin A (BrefA) to inhibit Golgi-vesicular 
traffic, the small peptide protein kinase inhibitor (PKI) to inhibit the protein kinase 
activated by cAMP (PKA), di-thiothreotol (DTT), MB and MEL to decrease 
cytosolic oxidation, and di-butyryl cyclic adenosine monophosphate (db-cAMP) to 
increase activity of PKA and the exchange protein activated by cAMP (Epac) 
(Togo, 2004). PEG was added immediately after transection for 1min and dye 
was added immediately after PEG was washed out. Compared to controls, the 




      
soma were significantly (p<0.001, CMH) and maximally enhanced by 10mM 
PEG.  Such PEG-sealing was at or near 100% and was not significantly (p>0.05) 
affected by Ca2+ (Fig. 3.3B) or any other substance tested that enhanced or 
decreased sealing probability (Fig. 3.3C).  All these data suggest that PEG 
directly produces membrane sealing (and thus PEG-sealing and PEG-fusion) 
independent of any known sealing pathway (Fig. A2). 
 
DISCUSSION  
Cut- or crush-severance lesions of mammalian peripheral nerves occur 
frequently and often produce significant behavioral deficits (Bozkurt et al., 2008; 
Campbell, 2008) even months-to-years post-injury even after treatment with the 
most-beneficial conventional techniques available today (microsurgery, nerve 
growth guides). In contrast, we now report for the first time that completely cut- or 
crush-severed rat sciatic nerves treated with our modified PEG-fusion protocols 
(Figs. A1, A3) show morphological and electrophysiological repair within minutes 
and dramatic behavioral recovery within 1-3 days that is maintained for at least 
12 weeks, i.e., permanent repair. Our in vitro, ex vivo, and in vivo data are all 
consistent with rationales and effects of our cut or crush PEG-fusion protocols as 
follows: (1) Ca2+-free hypotonic saline opens cut- or crush-severed axonal ends 
and brings them into close apposition in crush-severed nerves; open ends of cut-
severed nerves are closely apposed by microsutures through the epineurium; (2) 




      
ddH2O decreases vesicle formation at cut or crushed ends and reduces the 
probability that such ends partially collapse and seal; (3) Application of Ca2+-
containing isotonic saline seals any remaining plasmalemmal holes by enhancing 
vesicle formation, accumulation, interaction and fusion (Figs. A1, A3); (4) PEG-
fusion prevents much Wallerian degeneration. (5) PEG directly induces 
membrane fusion by removing waters of hydration at closely apposed 
membranes at severed axonal ends and small holes, thereby allowing membrane 
lipids in plasmalemmal leaflets to collapse, fuse and seal cut ends or to spread 
and seal smaller plasmalemmal disruptions (Bittner & Fishman, 2000; Lentz, 
2007; Fig. A4).  That is, PEG-sealing and/or PEG-fusion protocols are not 
affected by Ca2+, proteins or other substances in any other known membrane 
fusion or vesicle trafficking pathways (Figs.3.2-3).  Rather, PEG-sealing (and 
also almost-certainly PEG-fusion) depends upon PEG concentration with a 
parabolic- shaped dose-response curve (Fig. 3.2C).  
It is relevant for possible translation into clinical procedures that PEG-
induced fusion is almost certainly possible for other mammalian axons (including 
humans), as it is for many giant axons from several invertebrate phyla (Krause & 
Bittner, 1990; Lore et al., 1999), since cut- or crush-severed PNS or CNS axons 
in other mammals including rat, rabbit, and guinea pig sciatic or spinal tract 
axons can also be PEG-fused (Lore et al., 1999; Marzullo et al., 2002; Stavisky 
et al., 2005; Britt et al., 2010).  Furthermore, all drugs in our PEG-fusion 




      
are already FDA-approved for human use.  The applicability of these protocols 
beyond treating very acute traumatic nerve injuries is further indicated by our 
previously published data showing that (1) Cut-severed stumps of distal axons in 
rat tail nerves can be maintained morphologically and functionally intact for 5-10 
days by cooling this body part in vivo (Sea et al., 1995) or by cyclosporin A 
injections (Sunio & Bittner, 1997). (2) Distal axonal stumps of cut-severed rat 
spinal nerves maintained intact for days by cooling in vitro can be PEG-fused 
(Marzullo et al., 2002).  (3) Previously cut- or crush-severed axons that have 
sealed in Ca2+-containing saline can be recut, apposed and successfully sealed 
(Lore et al., 1999).  Consequently, our PEG-fusion protocols may indeed be 
quickly translatable to important clinical procedures that dramatically permanently 
restore within minutes-to-days much behavior lost by cut- or crush-axonal 
severance, a result not obtained by any other chemical or surgical treatment 
published to date.  











      
 
Fig. 3.1: (A,B), Mean CAP amplitudes normalized with respect to pre-operative 
amplitude recorded post-operatively from rat sciatic nerves ex vivo (Dye) or in 
vivo (Beh) for Cut (A) or Crush groups (B), as given by key in A or B.  (C,D) 
Mean SFI scores and (E,F) mean FF asymmetry scores for Cut (C,E) or Crush 
(D,F) treatment groups vs. post-operative week. Statistical comparisons: Cut SFI 
and FF graphs, * = Cut+Suture+MB+PEG vs. Cut+ Suture+PEG,curves, @ = 
Cut+Suture+PEG vs. Cut+Suture curves; SFI and FF crush graphs, * = 
Crush+MB+PEG vs. Crush+PEG at the same post-operative time. Single symbol 
= p<0.05, double symbol = p<0.01. Green triangle symbols = combined data for 
Cut+Suture+MB+PEG treatment group; dotted green line= CPK data, solid green 








      
 











      
Figure 3.2:  A,B:  Sealing probability (%) vs. post-calcium addition (PC) time of 
B104 cells with neurites transected >50µm (A) or <50µm (B) from the soma in 
Ca2+-free saline containing 2mM MEL (open squares) or 100µM MB (open 
circles) before adding Ca2+ or 10mM PEG (open triangles) for 1min after 
transection and then adding Ca2+. Solid lines: exponential fit to data. Asterisks: 
significant differences compared to control sealing (dotted, dashed lines); * = 
p<0.05, ** <0.01, *** <0.001. C: Sealing probability 1min after adding 2kDa PEG 
vs. log PEG concentration (mM) for B104 cells transected >50µM from the soma 
and maintained in Ca2+-containing saline (open squares) or Ca2+-free saline (gray 

























      
Figure 3.3A:  Sealing probability (%) vs. Post-PEG time (min) for B104 cells with 
neurites transected >50µm or <50µm from soma in Ca2+-free saline, treated with 
10mM PEG for 1min, and maintained in Ca2+-free saline (Solid lines). 
Dotted,dashed lines: Control sealing probability vs. PC time for cells transected 
>50µm or <50µm  from the soma in Ca2+-free saline and maintained in Ca2+-
containing saline. B:  Sealing probability (%) of B104 cells transected in Ca2+-
free saline at >50µm from the soma in the presence of substances that inhibit 
sealing, then treated with 10mM PEG in Ca2+-free saline, then bathed in Ca2+-
containing (open squares) or Ca2+-free (X) saline and immediately assessed for 
sealing. C: Sealing probability (%) of B104 cells transected >50µm from the 
soma in Ca2+-free saline containing an inhibitor of sealing, and assessed for 
sealing 5min after Ca2+ addition, i.e., at 5min PC. D: CAP amplitudes (mV) vs. 
time (min) recorded ex vivo (SI Fig. S1) from intact or crush-severed sciatic 
nerves exposed to isotonic saline (Krebs), hypotonic saline (Krebs+ ddH20) or 
2kDa PEG (500mM) dissolved in double-distilled water (ddH20). Data points: 














      
GENERAL DISCUSSION 
 While it has been known for over a century that mammalian peripheral 
nervous system axons are capable of regenerating following axotomy, it is also 
widely recognized by physicians and researchers that prognosis is often poor 
following traumatic nerve injury.  After severed distal axonal segments 
degenerate, proximal axonal ends grow towards their former targets at the rate of 
1-2 mm/day.  In larger mammals, such as humans, this rate of regeneration is 
slow enough that axons often never reach their targets due to changes in a 
complex extracellular environment following injury and inflammation.  Such 
changes may disrupt gradients of growth factors and cell adhesion molecules 
axonal outgrowths require to reach their appropriate destinations.  When 
regenerating axons are able to reach their targets after an extended period of 
time, those targets are often no longer receptive to innervation.  It will be 
important to provide neuroprotection treatments to prevent the loss of target 
neurons (Schallert & Lindner, 1990). 
 Much of the research exploring potential treatments for traumatic nerve 
injury has centered around improving guidance for slow axonal outgrowth.  Many 
such studies focus on silencing cell adhesion molecules that inhibit axonal 
outgrowth, or manipulating the extracellular environment with nerve growth 
conduits.  
PEG-fusion offers a rapid and effective repair strategy for crushed or 




      
together allows us to bypass both Wallerian degeneration and subsequent 
regeneration by axonal outgrowth.  This therapeutic strategy results in rapid 
recovery of lost behavioral function.  This advantage is critical in treating larger 
mammals (such as humans) because the many months or years it takes to 
regenerate axons to distal targets frequently results in those targets often no 
longer able to accept innervation.  Therefore, rapid repair by PEG-fusion not only 
increases the rate of behavioral recovery, but also results in a better overall 
prognosis than regeneration alone.   
In chapter one of this dissertation, we illustrate how PEG-fusion may be 
complemented by the administration of antioxidants following nerve injury.  
Oxidative stress is known as a component of secondary injury damage in axonal 
segments that have been crushed or severed.  By applying the antioxidant 
melatonin in vitro and in vivo to severed mammalian PNS axons, we 
demonstrated improved axonal viability following injury (as measured by CAP 
amplitude).  Additionally, in this section we were able to show that the application 
of melatonin enhances the success of PEG-fusion in severed mammalian PNS 
axons.   
Chapter two introduces evidence that PEG-fusion not only immediately 
restores axonal continuity, but also allows for rapid recovery of long-lasting 
behavioral function.  In this section we describe the use of two common 
behavioral tests for assessing hindlimb motor function in the rat.  Our results 




      
occurring in the first few weeks following injury, while the SFI appears to be more 
sensitive to subtle, persisting deficits in later weeks of recovery.  Through a 
series of experiments we attempt to show that PEG-fusion is a useful strategy for 
repairing crush-severed axons, providing lasting behavioral recovery following 
traumatic nerve injury.   
Chapter three introduces a detailed approach to treat nerve severance 
injuries using microsutures, the antioxidant methylene blue, and PEG-fusion.  
Cut-severed PNS axons typically regenerate more poorly than crush-severed 
axons, presumably due to lack of support and guidance of the ECM.  PEG-fusion 
alone typically provides inadequate repair because mechanical strength at the 
repair site is poor.  With microsutures we are able to bring proximal and distal 
severed axonal segments in close apposition.  Subsequent local application 
methylene blue in hypotonic, calcium-free saline leaves axonal ends open and 
vesicle-free.  We then demonstrate that PEG can fuse adjacent axonal ends and 
rapidly restore behavioral function in vivo.  Experiments in this section also 
suggest that PEG fuses and seals damaged membranes by a mechanism that is 
independent of Ca2+-mediated sealing. 
We do not know how many proximal and distal, cut or crushed, axonal 
segments are PEG-fused, the specificity of the motor or sensory proximal-distal 
axonal fusions, or the degree of rapidly or slowly occurring compensatory cortical 
or spinal plasticities that might compensate for any initial deficits.  Similar 




      
crush-severance of mammalian peripheral nerves.  However, the numbers and 
connection specificities of completely cut or crushed sciatic axons that are PEG-
fused are sufficient to produce within 1-3 days dramatic recovery of behaviors 
mediated by this nerve – and behavioral tests assessing such behaviors are the 
best measures of functional recovery, as opposed to electromyograms, counts of 
axonal numbers, extent of myelin sheathing, etc.  It is worth mentioning that I 
used epineural sheath landmarks in attempt to align severed proximal and distal 
nerve ends during microsuturing procedures in the experiments described in 
chapter three.  Another surgeon may not use such landmarks and it is unclear 
what effect, if any, this may have in the efficacy of PEG-fusion and subsequent 
behavioral recovery.  Furthermore, while it is known that Schwann cells align and 
aid in axonal regeneration of peripheral axons, it is possible such supportive cells 
may align and facilitate appropriate fusion of myelinated axons, as it is known 
that only six percent of sciatic axons are myelinated motor axons (Schmalbruch, 
1986).  Adding a mild oxidizing agent to the Ca2+-containing isotonic saline after 
applying PEG might further increase PEG-fusion success by enhancing the 
sealing of any remaining axolemmal holes in PEG-fused axons. Longer-term 
behavioral recovery might also be improved by applying trophic agents, nerve 
growth guides, or other techniques that moderately enhance the extent or 
specificity of regeneration at 1-2mm/day by axons that are not PEG-fused.  
Various exercise or training paradigms might also improve longer-term 




      
One of the difficulties in assessing behavioral outcome and treatment 
success following neural injury is that animals readily adopt compensatory 
behavioral strategies that can mask their true deficits (Schallert et al. 2000, 2002, 
2006).  A modified FF test eliminates much of this problem (Hernandez & 
Schallert 1988).  When injured rats walk on a grid surface, the impaired hindlimb 
frequently slips through the openings.  In the absence of a platform underlying 
the grid surface, rats typically learn motor strategies that reduce the number of 
slips, which obscure adequate evaluation of the degree of deficit.  Previous 
reports have indicated such compensation occurs, often involving a shift in the 
burden of weight support and locomotion to the uninjured limbs (Dellon and 
Dellon 1991).  Placing a solid platform just beneath the grid surface provides a 
“crutch” floor that the rats can use for support when their impaired hindlimb slips 
through the grid openings, allowing for a more sensitive detection of deficits 
(Schallert et al. 2002; Yang et al. 2006).  Unoperated or sham-operated rats 
rarely use the underlying solid floor surface during exploration of the grid.  In 
contrast, rats with sciatic nerve injuries frequently use the floor for support.   
The SFI is a computational assessment of three variables that measure 
print length, intermediary toe spread (digits 2-4) and total toe spread (digits 1-5).  
Previous studies have shown that the most useful parameter for overall 
evaluation of sciatic function is total toe spread (Bain et al. 1989; Bervar 2000).  
This factor deviates the most from control values, making it highly sensitive to 




      
quickly than distal muscles and SFI scores may be more heavily influenced by 
toe use and toe spread controlled by distal muscle groups compared to FF 
asymmetry scores.  Hence the SFI might be expected to show significant 
behavioral improvement later than FF asymmetry scores, and detect more 
chronic deficits, as we have reported.  
Neuroprotective effects of MB and MEL might enhance survival of severed 
axons, whether or not they have been PEG-fused, by increasing the number of 
PEG-fused axons and/or by improving survival of severed distal stumps or 
proximal axons not PEG-fused.  In the latter case, rescued axons might 
subsequently regenerate by conventional outgrowths at 1-2mm/day. These 
slowly regenerating outgrowths combined with relearning to use PEG-fused 
axons might account for the slow important increase in SFI and/or FF behavioral 
recovery after the second post-operative week.   
Future studies should consider using electromyographs to compare 
changes in electrophysiology with changes in behavior and function at various 
post-operative time points.  This would potentially provide useful insight into how 
fused vs. regenerating fibers may effect behavioral recovery in PEG-fused 
subjects.  Cutting the nerve after the subject has shown significant behavioral 
recovery is also an important control that should be addressed in future studies, 
to ensure that improvements in behavioral function did indeed stem from 
descending neural control, and not some unknown factor following PEG-fusion.  




      
groups in which the proximal and distal nerve segments are rotated 90 or 180 
degrees, assessing whether or not such intentional misalignment has any effect 
on the success of PEG-fusion and subsequent behavioral outcomes.   
It is hoped that prognosis for traumatic nerve injuries will be improved in 
the years to come.  The work described in this dissertation offers evidence that 
alternatives to regeneration by slow axonal outgrowth are possible.  Repair of 
damaged axons by PEG-fusion may contribute in the treatment of traumatic 
nerve injury giving rise to treatments that encourage a focus on rapid repair in 

















      
Appendix Figures 




Figure A1: Hypothesized effects of each solution used in sequence to produce 
PEG-fusion of crush-severed axons. Crush-severance completely disrupts the 
axolemma and the endoneural sheath (ENS) at the lesion site, but leaves the 
epineural sheath (EPS) mostly intact, insuring that crush-severed ends remain in 
close apposition. Consequently, PEG-fusion perhaps of the same axonal halves 
may occur more frequently for mammalian crush-severed axons in nerve bundles 
that are closely apposed by hypotonic salines within their original endoneural 
sheaths than for cut-severed axons closely apposed by microsutures, but whose 
cut ends cannot be precisely re-aligned. MEL: melatonin, MB: methylene blue, 








      


































      
Figure A2:  Model for endogenous, Ca2+-dependent, vesicle-mediated sealing, in 
which vesicles form a plug at a partly constricted transection site and site of 
minor plasmalemmal damage. Endogenous sealing in all eukaryotic cells likely 
occurs by this mechanism. PKA, PKC: phosphokinase A or C, Epac: exchange 
protein activated by cAMP, DAG: diacylglycerol. 
Data from invertebrate giant axons, sea urchin eggs, mammalian 
axons and non-neuronal mammalian cells consistently show that 
endogenous, naturally-occurring plasmalemmal sealing requires various 
proteins, many of whose isomers are Ca2+-dependent and involved in 
membrane fusion in synapses or the Golgi apparatus such as 
synaptobrevin, syntaxin, synaptophilin, synaptotagmin, calpains, TRIM 
proteins, PKA, and PKC (1-12). Increasing cAMP concentration, or 
specifically activating PKA or Epac via target-specific cAMP analogs, all 
produce similar increases in plasmalemmal sealing. Plasmalemmal 
sealing is decreased by an anti-oxidant (melatonin). That is, 
plasmalemmal sealing involves redundant, parallel pathways initiated by 
Ca2+ influx.  Furthermore, data from many different preparations from 
many diverse phyla show that isomers of the same proteins, pathways 
and vesicle interactions are likely involved in plasmalemmal sealing of all 
eukaryotic cells, indicating that such proteins in eukaryotes evolved to 
repair plasmalemmal damage. 
Immediately after plasmalemmal damage, extracellular Ca2+ flows in 
through the lesion site and activates sealing pathways (1-12; Fig. S2). This 
increase in internal free Ca2+ concentration ([Ca2+]i) also initiates processes that 
lead to axonal degeneration or cell death, often via apoptosis (1-4,6-9,12,13). 
Those neurons that do not quickly seal plasmalemmal damage do not survive or 
regenerate axonal processes (7,12,14), i.e., axolemmal sealing is often 
neuroprotective. B104 cells transected < 50 µm (nearer) from the soma seal at a 
slower rate compared to cells transected > 50 µm (farther) from the soma (3). 
However, axolemmal sealing does not guarantee neuronal survival after injury. 
Neurons that seal plasmalemmal damage at sites nearer to the soma are less 
likely to survive than neurons that seal plasmalemmal damage at sites further 
from the soma (3,7,12,14).  
The cut or crushed ends of severed distal axonal segments in 
invertebrates also seal by this same mechanism (1,2,4) – as do the severed 
distal ends of mammalian axons.  That is, Wallerian distal stump degeneration in 
24-72 hours in mammals is not due to an inability of the distal stump to seal, but 
rather to activation of endogenous proteases or phagocytosis by glia or other 
non-neuronal cells (1,2). 
 








      











      
Figure A3:  Hypothesized effects of each solution used in sequence to produce 
PEG-fusion of cut-severed axons. Cut-severance completely disrupts the 
axolemma as well as the endoneural (ENS), peri-neural and epineural (EPS) 
sheaths at the lesion site so that the cut ends typically separate by > 1mm. 
Microsutures placed in the EPS bring the proximal and distal cut axonal ends of 
sciatic nerves in close apposition. In rat sciatic and other mammalian nerve 
bundles, the PEG-fused cut ends are probably not the two halves of the same 















































Figure S4 legend:  PEG probably removes waters of hydration from membrane 
bound proteins at or near the damage site and decreases the activation energy 
required for plasmalemmal leaflets to fuse (1,2,15,16). Consequently, by 
removing bound water, especially in the absence of open, closely-apposed 
axonal segments (Fig. S5A,B), PEG causes damaged proximal axolemmal 
leaflets at severed axonal ends to collapse and fuse (i.e., PEG-seal, Fig. S5C) 
within seconds for rat sciatic nerves ex vivo and rat hippocampal B104 cells in 
vitro (Figs. 1A,B,2,3; Tables S1-S4, S9-S13). Small axolemmal holes are sealed 
by this removal of bound water, causing plasmalemmal lipids to flow into each 
other (1,2,15,16). Prior to 1994, transected axons were assumed to seal by 
collapse and fusion of plasmalemmal leaflets at cut ends and small holes to seal 
by spread of membrane lipids (4), as illustrated in Figure S5C. All such 
repair/sealing of complete plasmalemmal transections or small plasmalemmal 
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